SVM-light Version V5.01-TK-1.5
5 # kernel type
3 # kernel parameter -d 
1 # kernel parameter -g 
1 # kernel parameter -s 
1 # kernel parameter -r 
empty# kernel parameter -u 
0.4 # kernel parameter -L 
1 # kernel parameter -T 
S # kernel parameter -C 
1 # kernel parameter -F 
0 # kernel parameter -S 
0.400000 # kernel parameter -M 
3 # kernel parameter -N 
S # kernel parameter -V 
S # kernel parameter -W 
0 # kernel parameter -U 
2151 # highest feature index 
297 # number of training documents 
225 # number of support vectors plus 1 
0.99126269 # threshold b, each following line is a SV (starting with alpha*y)
-5.1698483124001830546490054985043  |BT| (S (NP (NP (ADVP (RB (Surprisingly)))(, (,))(VBN (given))(VBN (proposed))(NN (role))(NN (loss))(NN (function))(NN (mutation))(NN (p53))(NN (gene))(NN (development)))(NP (JJ (human))(JJ (colorectal))(NN (cancer)))(, (,)))(VP (VBD (found))(NP (NP (NN (evidence)))(PP (CC (either))(NP (NP (NN (increase))(NN (rate))(NN (adenoma))(NN (formation))(NN (APC)))(CC (+))(: (/))(: (-))(, (,))(NP (NN (p53))(: (-)))(: (/))(FRAG (: (-))(NP (NP (NN (animal)))(, (,))(NP (NP (VBD (increased))(NN (rate))(NN (progression))(NN (malignancy)))(VP (VBN (compared))(NP (NP (NN (APC)))(NP (CC (+))(: (/))(: (-))(NN (p53))(CC (+))(FRAG (: (/))(CC (+))(NP (NN (mouse))))))))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 12:Z01.542.049 13:D01.339.387 14:F01.525 15:F01.829.316.616 16:C23.550.291.656 17:C04.557.470.035 18:G05.365.590 19:B01.050 20:G03.495  |ES| 2:1 9:1 11:1 12:1 17:1 18:1 19:1 28:1 29:1 30:1 31:1 32:1 33:1 34:1 35:1 36:1 37:1 38:1 39:1 40:1 41:1 42:1 43:1 44:1 45:1 46:1 47:1 48:1 49:1 50:1 51:1 52:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (Notch-1))(NN (Notch-4))(JJ (potent))(NN (breast))(NN (oncogene)))(VP (VBN (overexpressed))(NP (JJ (triple-negative))(NNS (subtypes))(NN (breast))(NN (cancer))))) |ET|  |BS| 9:G05.360.340.024.340.375.500 10:A01.236  |ES| 18:1 19:1 20:1 21:1 22:1 23:1 24:1 25:1 26:1 27:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (ADJP (RB (Here))(VBN (studied)))(NN (role))(NN (HNF4alpha))(NN (mechanism))(NN (deregulation))(NN (Cdx2))(NN (colon))(NN (cancer)))) |ET|  |BS| 15:F01.829.316.616  |ES| 18:1 19:1 31:1 113:1 123:1 162:1 213:1 400:1 401:1 402:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Notch1)))(ADVP (RB (directly)))(VP (VBD (induced))(NP (NN (CD133))(NN (expression))(JJ (human))(JJ (diffuse))(NN (type))(JJ (gastric))(NN (cancer))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400  |ES| 18:1 19:1 36:1 86:1 115:1 412:1 543:1 621:1 651:1 652:1 653:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (DLGAP5))(NN (overexpression))(JJ (evident))(CD (25))(NN (%)))(PRN (-LRB- (-LRB-))(NP (QP (CD (22))(CD (88))))(-RRB- (-RRB-))))(NP (NP (NNP (HCC))(NN (specimen)))(PP (IN (without))(NP (NN (AFP))(NN (expression)))))(, (,))(S (VP (VBG (suggesting))(SBAR (S (NP (NN (DLGAP5)))(VP (MD (may))(NP (JJ (novel))(NN (biomarker))(NN (HCC))(NN (pathogenesis))))))))) |ET|  |BS| 104:C04.557.470.200.025.255 158:D23.101 259:D12.776.395.240.150.500  |ES| 2:1 10:1 14:1 19:1 115:1 152:1 369:1 441:1 491:1 501:1 885:1 891:1 1009:1 1127:1 1154:1 1191:1 1192:1 1193:1 1194:1 1195:1 1196:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (ADVP (RB (Collectively)))(, (,))(VP (VBP (result))(VP (VBP (suggest))(SBAR (S (NP (NN (loss))(JJ (multifunctional))(NN (miR-122)))(VP (VBZ (contributes))(NP (NP (JJ (malignant))(NN (phenotype))(NN (HCC))(NN (cell)))(, (,))(NP (NN (miR-122))(JJ (mimetic))(RB (alone))(NP (NN (combination))(JJ (anticancer))(NN (drug))))(NP (JJ (promising))(JJ (therapeutic))(NN (regimen))(NN (liver))(NN (cancer)))))))))) |ET|  |BS| 41:A11 52:E02 67:D26 80:G05.695 104:C04.557.470.200.025.255 231:C04.557.465.625.600.380.590 242:A03.620 531:E02.183.750 532:E02.183  |ES| 2:1 18:1 19:1 32:1 94:1 101:1 191:1 236:1 241:1 441:1 530:1 541:1 796:1 802:1 836:1 845:1 1517:1 1789:1 1872:1 1878:1 1879:1 1880:1 1881:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (ADJP (RB (Here))(VBN (studied)))(NN (role))(NN (HNF4alpha))(NN (mechanism))(NN (deregulation))(NN (Cdx2))(NN (colon))(NN (cancer)))) |ET|  |BS| 15:F01.829.316.616  |ES| 18:1 19:1 31:1 113:1 123:1 162:1 213:1 400:1 401:1 402:1  |EV| 
-2.1719989044106853270932333543897  |BT| (S (NP (ADJP (RB (Here))(VBN (investigated)))(NP (NN (role))(NN (Bcl-3))(NN (azoxymethane/dextran))(NN (sulfate))(NN (sodium)))(PRN (-LRB- (-LRB-))(NP (NN (AOM/DSS)))(-RRB- (-RRB-))))(: (-))(VP (VBN (induced))(NP (NP (NN (colon))(NN (tumor)))(, (,))(NP (NN (mouse))(NN (model))(JJ (colitis-associated))(JJ (colorectal))(NN (cancer)))(JJ (human))))) |ET|  |BS| 4:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 15:F01.829.316.616 51:C04.588.274.476.411.307.180 53:C06.405.205.265 55:B01.050.150.900.649.801.400.112.400.400 131:D09.698.365.272.300 132:D02.172.080  |ES| 2:1 7:1 10:1 14:1 17:1 18:1 19:1 31:1 36:1 52:1 72:1 113:1 400:1 403:1 404:1 405:1 406:1 407:1 408:1 409:1 410:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NN (AIM))(: (:)))(S (VP (TO (To))(VP (VB (define))(NP (NP (JJ (biological))(NN (contribution))(NNP (Hras))(NN (mouse))(NN (hepatocarcinogenesis)))(, (,))(VP (VBN (quantified))(S (FW (vivo))(NP (NN (interaction))(JJ (mutant))(NNP (Hras))(JJ (genetic))(NN (alteration)))(ADVP (RB (frequently)))(VP (VBN (associated))(NP (NP (NN (liver))(NN (cancer)))(, (,))(PP (VBG (including))(NP (NP (NN (overexpression))(NP (NN (transcription))(NN (factor))(NN (c-myc))(JJ (epidermal))(NN (growth))(NN (factor))(NN (receptor))(NN (ligand))(VBG (transforming))(NN (growth))(NN (factor))(NN (alpha))))(PRN (-LRB- (-LRB-))(NP (NN (TGFalpha)))(-RRB- (-RRB-)))))))))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 30:Z01.058.290.190.800 31:D08.811.520.224.800 64:D08.811.913.696.620.682.725.400.009.300 167:H01.158.273 170:D27.720.470.480 521:D08.811.277.040.330.300.400.500.600 522:D12.644.276.382.750 523:D12.776.260.676  |ES| 2:1 10:1 14:1 18:1 19:1 52:1 102:1 104:1 152:1 169:1 184:1 185:1 186:1 378:1 440:1 455:1 487:1 561:1 618:1 698:1 811:1 828:1 836:1 864:1 900:1 951:1 959:1 1360:1 1772:1 1832:1 1833:1 1834:1 1835:1 1836:1 1837:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (Differentiation))(NN (therapy))(JJ (hepatocellular))(NN (carcinoma))(NN (mouse))(JJ (recombinant))(NN (adenovirus)))(VP (VBG (carrying))(NP (NN (hepatocyte))(JJ (nuclear))(NN (factor-4alpha))(NN (gene))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 52:E02 74:G04.299.151 104:C04.557.470.200.025.255 247:G01.374.676.530 539:D20.215.894.899.024 540:D12.776.260.262 541:C02.256.076 542:B04.280.030  |ES| 9:1 19:1 52:1 130:1 303:1 304:1 850:1 1256:1 1420:1 1907:1 1908:1 1909:1 1910:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (ADVP (RB (Finally)))(, (,))(NP (NN (Apo-FHL2))(NN (mouse)))(VP (VBD (developed))(SBAR (S (NP (NP (NN (tumor)))(, (,))(NP (NN (FHL2))(NN (transgene))))(VP (VBD (enhanced))(SBAR (S (NP (NN (hepatocarcinogenesis)))(VP (VBD (induced))(NP (JJ (liver-specific))(NN (deletion))(NP (NP (JJ (adenomatous))(NN (polyposis))(NN (coli))(NN (gene))(JJ (aberrant))(NN (Wnt/beta-catenin))(NN (signaling))(NN (Apc)))(PRN (-LRB- (-LRB-))(NP (NN (lox/lox)))(-RRB- (-RRB-))))(NN (animal))))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 8:C04 11:B01.050.150.900.649.865.635.505.500 19:B01.050 21:G05.360.340.024.340.375.249.050 105:G02.149.115.800.925 242:A03.620 547:G05.360.340.024.340.825 548:D08.811.682.664.500.848 549:G05.355.600.800.320  |ES| 2:1 7:1 9:1 10:1 14:1 19:1 46:1 52:1 57:1 58:1 59:1 195:1 280:1 302:1 385:1 412:1 900:1 1059:1 1165:1 1725:1 1799:1 1929:1 1930:1 1931:1 1932:1 1933:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NP (NP (JJ (Altered))(NN (expression))(JJ (human))(NN (enhancer))(NN (filamentation))(CD (1)))(PRN (-LRB- (-LRB-))(NP (NP (NN (HEF1)))(: (;))(NP (ADJP (RB (also))(VBN (known)))(NN (NEDD9))(NN (Cas-L))))(-RRB- (-RRB-))))(NP (VBN (implicated))(NN (progression))(NN (melanoma))(, (,))(NN (breast))(, (,))(NN (CRC))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 10:A01.236 16:C23.550.291.656 55:B01.050.150.900.649.801.400.112.400.400 282:C04.557.465.625.650.510  |ES| 2:1 5:1 10:1 14:1 19:1 23:1 36:1 48:1 98:1 115:1 217:1 245:1 556:1 971:1 972:1 973:1 974:1 975:1 976:1 977:1 978:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (Overexpression))(NN (miR-141))(JJ (pancreatic))(NN (cancer))(NN (cell)))(VBD (inhibited))(NP (NN (cell))(NN (proliferation)))(, (,))(NP (NP (NN (clonogenicity)))(, (,))(NP (NN (invasion)))(: (;))(NP (VBN (induced))(NN (G1))(NN (arrest))(NN (apoptosis)))(: (;))(NP (VBN (enhanced))(NN (chemosensitivity)))))) |ET|  |BS| 39:G04.299.139.160 41:A11 122:C14.280.383 183:G04.299.233.750  |ES| 2:1 18:1 19:1 89:1 94:1 217:1 299:1 365:1 385:1 386:1 412:1 463:1 467:1 602:1 620:1 668:1 669:1 670:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (ADVP (RB (However)))(, (,))(SBAR (IN (whether))(S (NP (NN (up-regulation))(NN (DLGAP5)))(VP (VBZ (contributes))(NP (NN (hepatocarcinogenesis))))))(VP (VBZ (remains))(ADJP (JJ (unclear))))) |ET|  |BS| 142:I01.880.604  |ES| 2:1 19:1 221:1 433:1 442:1 443:1 845:1 896:1 900:1 1191:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (PURPOSE))(: (:)))(NP (DT (The))(NN (MYC))(NN (oncogene)))(ADVP (RB (frequently)))(VP (VBN (overexpressed))(NP (NN (prostate))(NN (cancer))))) |ET| 18:1 19:1 24:1 25:1 77:1 104:1 472:1 687:1 691:1 698:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NP (ADVP (RB (Surprisingly)))(, (,))(VBN (given))(VBN (proposed))(NN (role))(NN (loss))(NN (function))(NN (mutation))(NN (p53))(NN (gene))(NN (development)))(NP (JJ (human))(JJ (colorectal))(NN (cancer)))(, (,)))(VP (VBD (found))(NP (NP (NN (evidence)))(PP (CC (either))(NP (NP (NN (increase))(NN (rate))(NN (adenoma))(NN (formation))(NN (APC)))(CC (+))(: (/))(: (-))(, (,))(NP (NN (p53))(: (-)))(: (/))(FRAG (: (-))(NP (NP (NN (animal)))(, (,))(NP (NP (VBD (increased))(NN (rate))(NN (progression))(NN (malignancy)))(VP (VBN (compared))(NP (NP (NN (APC)))(NP (CC (+))(: (/))(: (-))(NN (p53))(CC (+))(FRAG (: (/))(CC (+))(NP (NN (mouse))))))))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 12:Z01.542.049 13:D01.339.387 14:F01.525 15:F01.829.316.616 16:C23.550.291.656 17:C04.557.470.035 18:G05.365.590 19:B01.050 20:G03.495  |ES| 2:1 9:1 11:1 12:1 17:1 18:1 19:1 28:1 29:1 30:1 31:1 32:1 33:1 34:1 35:1 36:1 37:1 38:1 39:1 40:1 41:1 42:1 43:1 44:1 45:1 46:1 47:1 48:1 49:1 50:1 51:1 52:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NNS (Tumors)))(VP (VBD (graded))(NP (NP (NN (histology))(JJ (immunostained))(NN (p53)))(, (,))(NP (JJ (adenomatous))(NN (polyposis))(NN (coli)))(, (,))(NP (NN (beta-catenin)))(, (,))(NP (NP (NP (NN (cyclooxygenase-2))(-LRB- (-LRB-))(NN (Cox-2))(-RRB- (-RRB-))(JJ (inducible))(JJ (nitric))(NN (oxide))(NN (synthase)))(PRN (-LRB- (-LRB-))(NP (NN (iNOS)))(-RRB- (-RRB-))))(VBN (sequenced))(NN (p53))(NN (mutation)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 3:C04.557.470.035.215.100 8:C04 18:G05.365.590 21:G05.360.340.024.340.375.249.050 22:D08.811.682.664.500.772.500 23:D12.776.091.249 24:D08.811.600.720.750 25:G02.111.570.080 26:G02.111.570.080 27:G02.111.570.080 28:H01.158.100.656  |ES| 2:1 10:1 12:1 14:1 19:1 34:1 53:1 54:1 55:1 56:1 57:1 58:1 59:1 60:1 61:1 62:1 63:1 64:1 65:1 66:1 67:1 68:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Isogenic))(JJ (LKB1-knockdown))(NN (breast))(NN (cancer))(NN (cell))(NN (line))(NN (pair)))(VP (VBD (developed)))) |ET|  |BS| 94:A11.251.210  |ES| 18:1 19:1 23:1 94:1 264:1 1165:1 2035:1 2036:1 2037:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (PP (IN (In))(NP (VBN (damaged))(NN (tissue))))(, (,))(NP (NP (JJ (combined))(NN (loss))(NN (RB))(NN (p53)))(VBD (resulted))(NP (JJ (early))(NN (lesion))(NN (formation)))(, (,))(NP (NP (JJ (aggressive))(NN (tumor))(NN (progression)))(, (,))(NP (NP (NN (gene))(NN (expression))(NN (signature)))(NP (JJ (histologic))(JJ (characteristic))(JJ (advanced))(JJ (human))(JJ (hepatocellular))(NN (carcinoma)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 8:C04 16:C23.550.291.656 20:G03.495 98:A10 104:C04.557.470.200.025.255 162:F01.145.126.125 384:G02.111.087.847.750 562:F01.510  |ES| 2:1 7:1 9:1 12:1 19:1 32:1 36:1 43:1 48:1 115:1 164:1 244:1 272:1 303:1 304:1 336:1 538:1 594:1 997:1 1128:1 1131:1 1209:1 1230:1 1991:1 1992:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (VBG (Activating))(NP (NN (alteration))(NN (variety))(JJ (potential))(JJ (oncogenic))(NN (driver))(NN (gene))))(ADVP (RB (also)))(VP (VBD (identified))(NP (NP (NNP (NSCLC)))(, (,))(PP (VBG (including))(NP (NN (ROS1))))(, (,))(NP (NNP (RET)))(, (,))(NP (NN (MET)))(, (,))(NP (NN (HER2)))(, (,))(NP (NN (BRAF)))))) |ET|  |BS| 18:G05.365.590 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 110:C04.588.894.797.520.109.220.249 278:D08.811.913.696.620.682.700.559.842.374 279:D27.888.569.100  |ES| 2:1 5:1 9:1 19:1 188:1 329:1 561:1 623:1 827:1 950:1 951:1 952:1 953:1 954:1 955:1 956:1 957:1 958:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (miR-221)))(VP (VBZ (Mediates))(NP (NNP (Chemoresistance))(NNP (Esophageal))(NNP (Adenocarcinoma))(NNP (Direct))(NN (Targeting))(NN (DKK2))(NN (Expression))))) |ET|  |BS| 38:Z01.058.290.120.180 40:Z01.542.248.700  |ES| 19:1 140:1 316:1 1215:1 2096:1 2097:1 2098:1 2099:1 2100:1 2101:1  |EV| 
-5.1698483124001830546490054985043  |BT| (FRAG (PP (IN (In))(NP (NN (study))))(, (,))(NP (VBN (explored))(NN (role))(NN (miR-141))(JJ (pancreatic))(NN (cancer)))) |ET|  |BS| 15:F01.829.316.616  |ES| 2:1 18:1 19:1 31:1 131:1 244:1 463:1 467:1 499:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (Induction))(NN (p53)))(VP (VBP (render))(NP (JJ (ATM-deficient))(NN (mouse))(JJ (refractory))(NN (hepatocarcinogenesis))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 11:B01.050.150.900.649.865.635.505.500  |ES| 12:1 19:1 52:1 900:1 2020:1 2021:1 2022:1 2023:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (DT (The))(NN (CDX2))(NN (expression))(JJ (gastric))(NN (cancer)))(ADVP (RB (also)))(ADVP (RB (inversely)))(VP (VBD (correlated))(NP (NN (expression))(JJ (gastric))(NN (mucin))))) |ET|  |BS| 72:D12.776.395.560.631.100  |ES| 5:1 18:1 19:1 86:1 114:1 115:1 209:1 418:1 446:1 691:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (ERBB4))(NN (alteration)))(NP (NP (NP (DT (The))(NN (Cancer))(NNP (Genome))(NNP (Atlas))(JJ (colorectal))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (CRC)))(-RRB- (-RRB-))))(NP (NP (NN (data))(NN (set))(JJ (stratified))(NN (survival)))(, (,))(VP (VBN (combined))(S (NP (NNP (Moffitt))(NNP (Cancer))(NNP (Center))(NNP (Vanderbilt))(NNP (Medical))(NNP (Center))(NN (CRC))(NN (expression))(NNS (data)))(VP (VBN (set))(, (,))(SBAR (S (NP (NN (ERBB4))(NN (message))(NN (level)))(VP (VBD (increased))(NP (NN (tumor))(NN (stage))))))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 8:C04 96:I03.784 97:V02.302 269:G05.360.340 544:A02.835.232.834.151.500 545:F02.463.425.838 546:V02.150  |ES| 2:1 7:1 10:1 14:1 17:1 18:1 19:1 47:1 115:1 164:1 245:1 249:1 274:1 691:1 793:1 951:1 1129:1 1679:1 1919:1 1920:1 1921:1 1922:1 1923:1 1924:1 1925:1 1926:1 1927:1 1928:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (addition))))(, (,))(NP (NN (PIM))(NN (kinase)))(VP (VBP (activate))(S (NP (NN (MYC))(NN (signaling))(NN (mRNA))(NN (translation))(NN (prostate))(NN (cancer)))(VP (VBP (cooperate))(S (NP (NN (MYC)))(VP (VB (accelerate))(NP (NN (tumorigenesis))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 32:C04.697.098.500 33:C04.697.098 69:G02.111.087.800 145:G02.111.087.675.871  |ES| 2:1 18:1 19:1 77:1 78:1 195:1 244:1 325:1 468:1 469:1 470:1 471:1 472:1 473:1 474:1 475:1  |EV| 
-3.9072566144737237436856958083808  |BT| (S (ADVP (RB (Herein)))(, (,))(VP (VBP (show))(SBAR (S (NP (NNP (NANOG)))(VP (VBD (expressed))(NP (NP (NN (NANOG1))(NN (NANOGP8))(JJ (human))(JJ (colorectal))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (CRC)))(-RRB- (-RRB-))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 55:B01.050.150.900.649.801.400.112.400.400  |ES| 2:1 6:1 10:1 14:1 17:1 18:1 19:1 36:1 245:1 428:1 429:1 430:1 431:1 432:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NN (study)))(VP (VBP (show))(SBAR (S (NP (NN (TS))(NN (gene))(NN (expression))(NN (pretreatment))(NN (biopsy)))(VP (VBZ (predicts))(NP (NN (response))(JJ (local))(JJ (rectal))(NN (cancer))(JJ (neo-adjuvant))(JJ (5-FU-based))(NN (chemoradiotherapy))(JJ (high))(NN (percentage)))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 154:Z01.058.266.887 155:G05.355.310 333:D01.045 559:E01.370.225.500.384.100 560:D03.383.742.698.875.404 561:E02.186.079.500  |ES| 2:1 9:1 18:1 19:1 115:1 131:1 178:1 244:1 429:1 494:1 509:1 1284:1 1751:1 1983:1 1984:1 1985:1 1986:1 1987:1 1988:1 1989:1 1990:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (PRP (We)))(VP (VBD (wanted))(VP (VB (determine))(SBAR (IN (whether))(S (NP (NP (JJ (genetic))(NN (defect))(JJ (relevant))(JJ (colorectal))(NN (cancer)))(, (,))(NP (NN (Msh2))(NN (p53))(NN (deficiency)))(, (,)))(VP (MD (would))(VP (VB (influence))(NP (NN (efficiency))(NN (sulindac))(NN (chemoprevention))(NN (increase))(NN (side))(NN (effect)))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 30:Z01.058.290.190.800 31:D08.811.520.224.800 87:C18.654.521 251:D02.455.426.559.847.486.875 252:F02.784.692.351 253:E02.319.162 254:C16.131  |ES| 2:1 12:1 17:1 18:1 19:1 40:1 74:1 75:1 221:1 253:1 585:1 588:1 843:1 863:1 864:1 865:1 866:1 867:1 868:1 869:1 870:1 871:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Silencing))(NN (MLH1)))(VP (ADVP (RB (frequently)))(VBN (seen))(S (NP (JJ (sporadic))(JJ (colorectal))(NN (cancer)))))) |ET|  |BS| 4:C04.588.274.476.411.307 213:F02.830.816.964  |ES| 17:1 18:1 19:1 698:1 722:1 723:1 724:1 725:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (Alteration))(NN (Apc))(NN (gene)))(VP (VBN (shown))(NP (NP (NN (play))(JJ (important))(NN (role)))(JJ (PhIP-induced))(JJ (IQ-induced))(NN (rat))(NN (colon))(NN (carcinogenesis))))) |ET|  |BS| 3:C04.557.470.035.215.100 15:F01.829.316.616 18:G05.365.590 30:Z01.058.290.190.800 31:D08.811.520.224.800 33:C04.697.098 46:A03.556.124.526.356 79:I03.450.642.693 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700  |ES| 9:1 19:1 31:1 113:1 207:1 237:1 238:1 280:1 849:1 902:1 1838:1 1839:1 1840:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Microsomal))(NN (prostaglandin))(NN (E))(NN (synthase-1)))(VP (VBN (involved))(NP (JJ (multiple))(NN (step))(NN (colon))(NN (carcinogenesis))))) |ET|  |BS| 33:C04.697.098 46:A03.556.124.526.356  |ES| 19:1 113:1 207:1 649:1 774:1 2083:1 2084:1 2085:1 2086:1 2087:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NP (NN (Mutation))(NN (Pla2g2a)))(, (,))(NP (JJ (secretory))(NN (phospholipase))(NN (A))(-LRB- (-LRB-))(CD (2))(-RRB- (-RRB-)))(NP (NN (gene)))(, (,)))(VP (VP (ADVP (RB (dramatically)))(VB (increase))(NP (NN (number))(JJ (intestinal))(NN (polyp)))(VP (VB (develop))(NP (NP (NP (JJ (multiple))(JJ (intestinal))(NN (neoplasia)))(PRN (-LRB- (-LRB-))(NP (NN (Min)))(-RRB- (-RRB-))))(NN (mouse)))))(, (,))(NP (JJ (murine))(ADJP (NN (model))(JJ (adenomatous))(NN (polyposis))(NN (coli))(JJ (human)))))) |ET|  |BS| 3:C04.557.470.035.215.100 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 21:G05.360.340.024.340.375.249.050 55:B01.050.150.900.649.801.400.112.400.400 102:C04.588.274.476.411 192:D08.811.277.352.100.680.750.937.750 193:C23.300.825.411  |ES| 2:1 9:1 10:1 14:1 19:1 36:1 40:1 52:1 57:1 58:1 59:1 69:1 72:1 109:1 148:1 627:1 640:1 641:1 642:1 643:1 644:1 645:1 646:1 647:1 648:1 649:1 650:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NN (WT1)))(VP (VBD (expressed))(NP (NP (JJ (substantial))(NN (proportion))(NN (HCC)))(VP (VBG (contributing))(NP (NN (tumor))(NN (progression))(NN (resistance))(NN (chemotherapy)))))(, (,))(S (VP (VBG (suggesting))(SBAR (S (NP (NN (WT1)))(VP (MD (may))(NP (JJ (important))(NN (target))(NN (HCC))(NN (treatment)))))))))) |ET|  |BS| 8:C04 12:Z01.542.049 16:C23.550.291.656 52:E02 104:C04.557.470.200.025.255 151:E02.319 382:C04.557.435.595  |ES| 2:1 6:1 7:1 19:1 48:1 160:1 244:1 441:1 491:1 495:1 546:1 902:1 1009:1 1094:1 1284:1 1292:1 1293:1 1294:1 1295:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (S (VP (VBG (finding))(S (VP (VBP (indicate))(SBAR (S (NP (NN (miR-375))(NN (target))(NN (AEG-1))(NN (HCC)))(VP (VBZ (suppresses))(NP (NN (liver))(NN (cancer))(NN (cell))(NN (growth)))(ADVP (FW (vitro))(FW (vivo))))))))))(, (,))(NP (NN (highlight))(JJ (therapeutic))(JJ (potential))(NN (miR-375))(NN (HCC))(NN (treatment)))))) |ET|  |BS| 41:A11 45:G07.700.320.249 52:E02 104:C04.557.470.200.025.255 262:A11.436.348  |ES| 2:1 18:1 19:1 94:1 102:1 160:1 216:1 244:1 378:1 441:1 541:1 546:1 686:1 827:1 836:1 927:1 1284:1 1479:1 1675:1 1975:1 1976:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NNP (Hepatitis))(NNP (C))(JJ (virus-induced))(NN (up-regulation))(NN (microRNA-155)))(VP (VBZ (promotes))(NP (NN (hepatocarcinogenesis))(VBG (activating))(NN (Wnt))(NN (signaling))))) |ET|  |BS| 69:G02.111.087.800 184:D13.150.650.319 249:G05.355.315.800 339:G02.111.087.880 550:B04.450.410  |ES| 19:1 195:1 298:1 877:1 896:1 900:1 1954:1 1955:1 1956:1 1957:1 1958:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (JJ (Dual))(JJ (therapeutic))(NN (effect))(NN (interferon-alpha))(NN (gene))(NN (therapy))(NN (rat))(JJ (hepatocellular))(NN (carcinoma))(NN (model))(NN (liver))(NN (cirrhosis)))) |ET|  |BS| 104:C04.557.470.200.025.255 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 356:D12.644.276.374.440.890.250 357:C06.552.630  |ES| 9:1 19:1 72:1 75:1 130:1 303:1 304:1 541:1 836:1 849:1 1197:1 1198:1 1199:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Expression))(NN (DRD2)))(VP (VBZ (Is))(SBAR (S (NP (VBN (Increased))(JJ (Human))(JJ (Pancreatic))(JJ (Ductal))(NN (Adenocarcinoma))(NNS (Inhibitors)))(VP (VBP (Slow))(NP (NN (Tumor))(NN (Growth))(NNS (Mice)))))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 55:B01.050.150.900.649.801.400.112.400.400 362:D12.776.543.750.069.300.400.500 363:C04.557.470.200.025.232.750 364:D27.505.696.377.450  |ES| 19:1 316:1 444:1 583:1 1210:1 1211:1 1212:1 1213:1 1214:1 1215:1 1216:1 1217:1 1218:1 1219:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(UCP (PP (IN (In))(NP (NN (mouse))))(, (,))(NP (NP (NN (fucosylation))(NN (deficiency))(NN (lead))(NN (colitis))(NN (adenocarcinoma)))(, (,))(NP (NN (loss))(NN (Notch))(NN (activation)))(, (,))(NP (NN (down-regulation))(NN (Hes1)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 53:C06.405.205.265 84:C04.557.470.200.025 85:G02.111.087.225 86:D01.268.556.435 87:C18.654.521  |ES| 2:1 19:1 32:1 52:1 104:1 143:1 225:1 239:1 244:1 252:1 253:1 254:1 255:1 256:1 257:1 258:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (PRP$ (Our))(NNS (data)))(VP (VBP (suggest))(NP (JJ (important))(NP (NN (role))(NN (beta2-AR/STAT3/miR))(CD (-373))(NN (signaling))(NN (transformation))(JJ (gastric))(NN (cancer))(NN (cell)))))) |ET|  |BS| 12:Z01.542.049 15:F01.829.316.616 41:A11 69:G02.111.087.800 82:D12.644.360.024.342.300  |ES| 18:1 19:1 31:1 86:1 94:1 195:1 658:1 793:1 796:1 902:1 1384:1 2144:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (MicroRNA-375))(NN (target))(NN (AEG-1))(JJ (hepatocellular))(NN (carcinoma)))(VP (VBZ (suppresses))(NP (NN (liver))(NN (cancer))(NN (cell))(NN (growth)))(ADVP (FW (vitro))(FW (vivo))))) |ET|  |BS| 41:A11 45:G07.700.320.249 104:C04.557.470.200.025.255 184:D13.150.650.319 262:A11.436.348  |ES| 18:1 19:1 94:1 102:1 160:1 216:1 303:1 304:1 378:1 686:1 836:1 1976:1 2076:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (SBAR (IN (Because))(S (NP (NN (Notch))(NN (signaling))(VBN (implicated))(NN (colon))(NN (cancer))(NN (tumorigenesis)))(VP (VBZ (protects))(NP (NP (NN (cell))(NN (apoptosis)))(VP (VBG (inducing))(NP (JJ (prosurvival))(NN (target))))))))(, (,))(VP (VBD (hypothesized))(SBAR (S (NP (NP (NN (inhibition))(NN (Notch))(NN (signaling))(NN (gamma-secretase))(NN (inhibitor)))(PRN (-LRB- (-LRB-))(NP (NN (GSI)))(-RRB- (-RRB-))))(VP (MD (may))(NP (VB (enhance))(NP (NN (chemosensitivity))(NN (colon))(NN (cancer))(NN (cell))))))))) |ET|  |BS| 32:C04.697.098.500 33:C04.697.098 39:G04.299.139.160 41:A11 43:F01.145.544 69:G02.111.087.800 125:D08.811.277.656.300.032  |ES| 2:1 10:1 14:1 18:1 19:1 78:1 89:1 94:1 103:1 113:1 160:1 195:1 256:1 380:1 386:1 491:1 977:1 1690:1 1750:1 1862:1 1863:1 1864:1 1865:1 1866:1 1867:1  |EV| 
5.1698483124001830546490054985043  |BT| (FRAG (PP (IN (In))(NP (NN (context))))(, (,))(NP (NP (NP (NN (study))(NN (p53)))(NP (ADVP (RB (therefore)))(NP (JJ (obvious))(NN (implication))(JJ (human))(NN (health))(NN (performance)))))(, (,))(NP (NP (VBN (given))(JJ (impaired))(JJ (mitochondrial))(NN (content))(NN (function)))(VBN (associated))(NN (pathology))(JJ (many))(JJ (metabolic))(NN (disorder)))(NP (JJ (ageing))(, (,))(NN (type))(CD (2))(NN (diabetes)))(, (,))(NP (NN (obesity))(NN (cancer)))(, (,))(NP (ADJP (RB (well))(VBN (reduced)))(NN (exercise))(NN (performance))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 55:B01.050.150.900.649.801.400.112.400.400 564:C18.654.726.500 565:A11.284.430.214.190.875.564 566:G11.427.590.530.698.277 567:G05.360.340.024.340.365 568:C18.452.394.750.149 569:G07.700.320.124 570:C23.550 571:N01.400  |ES| 2:1 12:1 18:1 19:1 29:1 33:1 36:1 85:1 131:1 148:1 169:1 218:1 244:1 452:1 543:1 787:1 1040:1 1794:1 1999:1 2000:1 2001:1 2002:1 2003:1 2004:1 2005:1 2006:1 2007:1 2008:1 2009:1 2010:1 2011:1  |EV| 
-2.3410224692379415500909090042114  |BT| (S (NP (NN (LINE-1))(NN (methylation)))(VP (VBD (decreased))(SBAR (S (NP (NN (transition))(JJ (intestinal))(NN (metaplasia))(JJ (gastric))(NN (adenoma))(NN (decrease)))(VP (VBD (occurred))(NP (NN (transition))(JJ (gastric))(NN (adenoma))(NN (GC)))))))) |ET|  |BS| 17:C04.557.470.035 36:G02.111.087.029.538 47:A03.556.124 48:C23.550.589 70:A03.556.875.875  |ES| 19:1 42:1 81:1 86:1 109:1 110:1 202:1 295:1 551:1 552:1 553:1 554:1  |EV| 
-4.2443638408340618184411141555756  |BT| (NP (NP (NN (INTRODUCTION)))(: (:))(NP (NP (NP (NP (JJ (Triple))(JJ (negative))(NN (breast))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (TNBC)))(-RRB- (-RRB-))))(NP (JJ (aggressive))(ADJP (RB (currently))(JJ (specific)))(JJ (therapeutic))(NN (target))))(, (,))(NP (NP (NN (hormone))(NN (receptor))(JJ (human))(JJ (epidermal))(NN (growth))(NN (factor))(NN (receptor))(NN (type))(CD (2)))(PRN (-LRB- (-LRB-))(NP (NN (HER2)))(-RRB- (-RRB-)))))(: (;))(ADVP (RB (therefore)))(, (,))(NP (NN (prognosis))(JJ (poor)))) |ET|  |BS| 52:E02 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 159:I01.880.735.634 160:C04.588.180.788 161:D06.472 162:F01.145.126.125 163:E01.789  |ES| 2:1 10:1 14:1 18:1 19:1 23:1 36:1 102:1 104:1 148:1 160:1 184:1 185:1 186:1 188:1 217:1 218:1 449:1 535:1 536:1 537:1 538:1 539:1 540:1 541:1 542:1 543:1 544:1 545:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (ADVP (RB (Here)))(, (,))(VP (VBD (investigated))(NP (NP (JJ (molecular))(NN (mechanism)))(VP (VBG (underlying))(NP (JJ (oncogenic))(NN (cooperation))(NN (c-Myc))(NN (E2F1))(NN (relationship))(JJ (human))(NN (liver))(NN (cancer))))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 279:D27.888.569.100  |ES| 2:1 18:1 19:1 36:1 161:1 162:1 223:1 400:1 403:1 435:1 824:1 836:1 953:1 1960:1 1961:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NN (ALK))(NN (gene))(NN (copy))(NN (number)))(NP (NN (gain))(JJ (clinical))(NN (significance))(JJ (hepatocellular))(NN (carcinoma)))) |ET|  |BS| 104:C04.557.470.200.025.255 280:G05.380.350  |ES| 9:1 19:1 84:1 303:1 304:1 557:1 646:1 962:1 963:1 964:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (MicroRNA-7)))(VP (VBZ (inhibits))(NP (NP (NN (tumor))(NN (growth))(NN (metastasis)))(VP (VBG (targeting))(NP (NN (phosphoinositide))(NN (3-kinase/Akt))(NN (pathway))(JJ (hepatocellular))(NN (carcinoma))))))) |ET|  |BS| 8:C04 45:G07.700.320.249 104:C04.557.470.200.025.255 113:C04.697.650 122:C14.280.383 184:D13.150.650.319 378:D08.811.913.696.620.682.700.755 578:D08.811.913.696.620.550  |ES| 7:1 19:1 102:1 303:1 304:1 383:1 615:1 616:1 806:1 2079:1 2080:1 2081:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Detection)))(VP (VBN (methylated))(S (NP (NN (PAX5)))(VP (VBD (utilized))(NP (JJ (independent))(JJ (prognostic))(NN (factor))(NN (GC))))))) |ET|  |BS| 36:G02.111.087.029.538 243:D12.776.260.645.500  |ES| 19:1 185:1 554:1 846:1 883:1 884:1 1179:1 1180:1 1182:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (BACKGROUND)))(CC (&))(NP (NNS (AIMS))))(: (:))(S (NP (NP (NN (p53))(NNS (Mutations)))(JJ (common))(NP (JJ (human))(JJ (hepatocellular))(NN (carcinoma)))(, (,))(NP (NN (induction))(JJ (hepatic))(NN (p53))(NN (expression))))(VP (VBP (cause))(SBAR (S (NP (NN (lysis)))(VP (VBD (implanted))(NP (NN (hepatoblastoma))(NN (cell))(JJ (chimeric))(NN (mouse))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 41:A11 55:B01.050.150.900.649.801.400.112.400.400 73:N05.715.350.200 104:C04.557.470.200.025.255 504:C04.557.435.380 505:B05.200  |ES| 2:1 12:1 19:1 36:1 52:1 94:1 104:1 115:1 303:1 304:1 655:1 736:1 838:1 1046:1 1410:1 1777:1 1778:1 1779:1 1780:1 1781:1 1782:1 1783:1  |EV| 
-0.35840016670181285007856786251068  |BT| (S (NP (NN (HDAC8))(NN (STAT3)))(VP (VBP (repress))(NP (NN (BMF))(NN (gene))(NN (activity))(NN (colon))(NN (cancer))(NN (cell))))) |ET|  |BS| 6:G05.360.340.024.340 9:G05.360.340.024.340.375.500 41:A11 46:A03.556.124.526.356 82:D12.644.360.024.342.300  |ES| 9:1 18:1 19:1 94:1 113:1 251:1 396:1 397:1 398:1 399:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (DEPDC1)))(VP (VBD (required))(NP (NN (cell))(NN (cycle))(NN (progression))(NN (motility))(JJ (nasopharyngeal))(NN (carcinoma))))) |ET|  |BS| 16:C23.550.291.656 353:G04.299.134  |ES| 19:1 48:1 94:1 304:1 601:1 1174:1 1176:1 1177:1 1178:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NN (CONCLUSION)))(: (:))(S (NP (DT (The))(NN (outcome))(NN (study)))(VP (VBP (represent))(NP (JJ (significant))(NN (contribution))(JJ (current))(NN (understanding))(JJ (preventive))(NN (mechanism))(NN (quercetin))(JJ (early))(NN (stage))(NN (liver))(NN (cancer))(NN (development)))(, (,))(S (VP (VBG (demonstrating))(NP (NP (NN (addition)))(VP (VBN (known))(VP (JJ (proapoptotic))(ADJP (ADJP (JJ (characteristic)))(, (,))(SBAR (S (NP (NN (flavonoid)))(VP (VBZ (modulates))(NP (NP (NN (expression))(JJ (critical))(NN (cell))(NN (cycle))(NN (regulator)))(NN (peroxisome))(NN (proliferator))(VBD (activated))(NN (receptor-alpha))(NN (activity))))))))))))))) |ET|  |BS| 239:F02.463.188.357 242:A03.620 353:G04.299.134 473:E01.789.625 533:D03.383.663.283.266.450.284.777 534:D03.383.663.283.266.450 535:H01.770.644.145.431 536:D12.776.826.239.500  |ES| 2:1 18:1 19:1 35:1 94:1 104:1 115:1 131:1 135:1 162:1 163:1 175:1 235:1 336:1 399:1 468:1 527:1 547:1 556:1 601:1 606:1 691:1 799:1 825:1 836:1 905:1 1128:1 1129:1 1360:1 1882:1 1883:1 1884:1 1885:1 1886:1 1887:1 1888:1 1889:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NN (Microsatellite))(NN (instability))(NN (tool))(NN (classification))(JJ (gastric))(NN (cancer)))) |ET|  |BS| 395:L01.100 538:C23.550.362.590  |ES| 18:1 19:1 86:1 831:1 1299:1 1338:1 2082:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Further))(NN (study))(NN (mechanism))(NN (ADCY3))(NN (tumorigenesis)))(VP (VBP (provide))(NP (NN (basis))(JJ (new))(JJ (molecular))(NN (target))(JJ (gastric))(NN (cancer))))) |ET|  |BS| 32:C04.697.098.500 33:C04.697.098  |ES| 18:1 19:1 78:1 86:1 131:1 160:1 161:1 162:1 330:1 711:1 712:1 1140:1 1934:1  |EV| 
-1.3177402621638520940905436873436  |BT| (S (NP (JJ (Aldo-keto))(NN (reductase))(NN (family))(CD (1))(NN (B10))(NN (gene))(NN (silencing)))(VP (VBP (result))(NP (NP (NN (growth))(NN (inhibition))(JJ (colorectal))(NN (cancer))(NN (cell)))(: (:))(NP (NP (NN (Implication))(NN (cancer)))(NN (intervention)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 41:A11 42:G05.355.315.203.374 43:F01.145.544 44:F01.829.263 45:G07.700.320.249  |ES| 9:1 17:1 18:1 19:1 94:1 95:1 96:1 97:1 98:1 99:1 100:1 101:1 102:1 103:1 104:1 105:1 106:1  |EV| 
-2.6933628082156317873341322410852  |BT| (S (NP (JJ (Chromosomal))(NN (analysis)))(VP (VBD (revealed))(SBAR (S (NP (NP (JJ (close))(JJ (genetic))(NN (relationship))(NN (papillary))(JJ (urothelial))(JJ (choriocarcinomatous))(NN (tumor))(NN (component)))(, (,))(VP (VBG (documenting))(NP (JJ (first))(NN (time))(NN (choriocarcinoma))(JJ (renal))(NN (pelvis)))))(VP (VBP (result))(NP (JJ (clonal))(NN (evolution))(JJ (urothelial))(NN (carcinoma))(NN (acquisition))(JJ (trophoblastic))(NN (differentiation)))))))) |ET|  |BS| 8:C04 74:G04.299.151 149:G05.360.340.024.340.364.875.890 289:A11.284.187 316:C04.557.465.955.207 317:C04.557.470.200.430 318:A05.810.453.537 319:A11.382.992 320:G04.299.350 321:A10.272.850 322:G01.910  |ES| 2:1 7:1 19:1 101:1 215:1 223:1 275:1 304:1 661:1 816:1 864:1 922:1 1021:1 1069:1 1075:1 1076:1 1077:1 1078:1 1079:1 1080:1 1081:1 1082:1 1083:1 1084:1 1085:1 1086:1  |EV| 
-4.9819491981946839587180875241756  |BT| (S (NP (NN (Wnt/beta-catenin))(NN (signaling))(JJ (critical))(JJ (intestinal))(NN (cell))(NN (proliferation)))(, (,))(VP (VBD (decreased))(NP (NN (CDX2))(NN (expression))(NN (influence))(NN (Wnt))(JJ (signaling-related))(NN (gene))(NN (progression))(JJ (colorectal))(NN (cancer))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 16:C23.550.291.656 47:A03.556.124 69:G02.111.087.800 105:G02.149.115.800.925 183:G04.299.233.750  |ES| 2:1 9:1 17:1 18:1 19:1 48:1 94:1 109:1 114:1 115:1 195:1 202:1 299:1 302:1 825:1 867:1 877:1 878:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(VP (VBP (suggest))(SBAR (S (NP (NN (change))(NN (level))(NN (cdk4)))(VP (MD (may))(NP (JJ (useful))(NN (biomarker))(NN (detection))(NN (HCC)))))))) |ET|  |BS| 104:C04.557.470.200.025.255 158:D23.101  |ES| 2:1 19:1 200:1 244:1 249:1 441:1 491:1 796:1 885:1 1023:1 1036:1 1284:1 1291:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NP (DT (A))(NP (NP (JJ (genetic))(NN (basis))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(JJ (well-established))(JJ (major))(NN (signaling))(NN (pathway)))(, (,))(NP (NP (NN (p53)))(, (,))(NP (NN (Wnt-signaling)))(, (,))(NP (NP (NP (VBG (transforming))(NN (growth))(NN (factor-beta)))(PRN (-LRB- (-LRB-))(NP (NN (TGF-beta)))(-RRB- (-RRB-))))(NN (Ras))(NN (pathway))))(, (,)))(VP (VBD (identified))(NP (JJ (essential))(NN (HCC))(NN (development))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 2:G05.360.340.024.340.375.249.385 30:Z01.058.290.190.800 31:D08.811.520.224.800 69:G02.111.087.800 104:C04.557.470.200.025.255 126:G02.111.087.800 149:G05.360.340.024.340.364.875.890 503:D12.644.276.374.687  |ES| 2:1 10:1 12:1 14:1 19:1 35:1 69:1 102:1 195:1 303:1 304:1 383:1 441:1 462:1 623:1 864:1 1140:1 1770:1 1771:1 1772:1 1773:1 1774:1 1775:1 1776:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (PP (IN (As))(NP (JJ (key))(NN (molecule))(NN (drive))(NN (progression))(NN (chemoresistance))(JJ (gastrointestinal))(NN (cancer))))(, (,))(NP (NP (NP (JJ (epidermal))(NN (growth))(NN (factor))(NN (receptor)))(PRN (-LRB- (-LRB-))(NP (NN (EGFR)))(-RRB- (-RRB-))))(NN (HER2)))(VP (VBP (become))(NP (JJ (efficacious))(NN (drug))(NN (target))(NN (setting))))) |ET|  |BS| 16:C23.550.291.656 63:G05.360.340.024.340.375.500.791.295.305 64:D08.811.913.696.620.682.725.400.009.300 65:D08.811.913.696.620.682.725.400.009.400 66:F01.658.293 67:D26  |ES| 2:1 10:1 14:1 18:1 19:1 48:1 102:1 159:1 160:1 168:1 180:1 181:1 182:1 183:1 184:1 185:1 186:1 187:1 188:1 189:1 190:1 191:1 192:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Intestinal))(NN (cancer)))(VP (VBN (driven))(SBAR (S (NP (ADJP (RB (purely))(NN (PTEN-deficiency)))(JJ (transgenic))(NN (mouse)))(VP (VBD (developed))(NP (NP (NN (CM))(JJ (human))(NN (CRC)))(, (,))(NP (NP (NN (CM)))(VP (VBN (associated))(NP (NNP (PTEN))(NNP (PRKCZ))(NN (readout))))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 55:B01.050.150.900.649.801.400.112.400.400 66:F01.658.293 87:C18.654.521 99:B01.050.050.136.500 101:C04.588.274.476.411  |ES| 2:1 18:1 19:1 36:1 52:1 169:1 204:1 245:1 285:1 920:1 1165:1 1936:1 2030:1 2031:1 2032:1 2033:1 2034:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (JJ (Genomic))(NN (Sequencing)))(VP (VBZ (Identifies))(NP (NN (ELF3))(NN (Driver))(NNP (Ampullary))(NNP (Carcinoma))))) |ET|  |BS| 265:C04.557.470.200 268:H01.158.273.180.350 269:G05.360.340  |ES| 19:1 1235:1 1236:1 1237:1 1238:1 1239:1 1240:1 1241:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (PRP$ (Our))(NN (finding))(NN (support))(JJ (mir-660))(NN (act))(NN (tumor))(NN (suppressor))(NN (miRNA)))(VP (VBP (suggest))(NP (NN (replacement))(JJ (mir-660))(JJ (new))(JJ (therapeutic))(NN (approach))(NN (p53))(JJ (wild-type))(NN (lung))(NN (cancer))(NN (treatment))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 52:E02 81:E02.095.465.425.400.330.050.400 181:E04.936.494 184:D13.150.650.319 206:G05.360.340.024.340.375.249 275:C23.888 375:Z01.639.100  |ES| 7:1 8:1 12:1 18:1 19:1 246:1 328:1 373:1 541:1 546:1 614:1 658:1 700:1 712:1 796:1 840:1 911:1 927:1 1364:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NNP (Gene))(NN (amplification))(NN (17q))(JJ (chromosomal))(NN (region)))(VP (VBN (observed))(ADVP (RB (frequently)))(NP (NN (breast))(NN (cancer))))) |ET|  |BS| 292:Z01 368:C23.550.210.182  |ES| 18:1 19:1 23:1 261:1 667:1 698:1 921:1 1002:1 1233:1 1234:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (BACKGROUND)))(CC (&))(NP (NNS (AIMS))))(SBAR (: (:))(S (S (NP (NNS (Mutations))(NN (APC))(NN (gene)))(VP (VBP (result))(VP (VBN (increased))(S (NP (NN (propensity)))(VP (VB (develop))(NP (JJ (intestinal))(NN (neoplasia))))))))(: (;))(S (ADVP (RB (however)))(, (,))(NP (NP (JJ (complete))(NN (understanding))(NN (mechanism)))(VP (VBG (resulting))(NP (NN (tumor))(NN (formation)))))(VP (VBD (remained))(ADJP (JJ (elusive)))))))) |ET|  |BS| 8:C04 18:G05.365.590 20:G03.495 21:G05.360.340.024.340.375.249.050 30:Z01.058.290.190.800 31:D08.811.520.224.800 102:C04.588.274.476.411 239:F02.463.188.357  |ES| 2:1 7:1 9:1 11:1 19:1 43:1 47:1 101:1 104:1 109:1 162:1 172:1 217:1 384:1 640:1 648:1 777:1 905:1 1046:1 1387:1 1410:1 1777:1 1778:1 1860:1 1861:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Additional))(NN (qRT-PCR))(NN (analysis)))(VP (VBD (revealed))(S (NP (JJ (gradual))(NN (elevation))(VBG (circulating))(NNS (miRNAs)))(-LRB- (-LRB-))(NP (FRAG (NP (FW (i.e.))(, (,))(NN (let-7a))(, (,))(NN (let-7f))(, (,))(NN (miR-34a))(, (,))(NN (miR-98))(, (,))(NN (miR-331))(, (,))(NN (miR-338))(NN (miR-652))(-RRB- (-RRB-))(NN (progress))(NN (hepatocarcinogenesis)))))))) |ET|  |BS| 184:D13.150.650.319 448:E05.393.620.500  |ES| 2:1 10:1 14:1 19:1 275:1 661:1 876:1 888:1 900:1 1110:1 1623:1 1821:1 1822:1 1823:1 1824:1 1825:1 1826:1 1827:1 1828:1 1829:1 1830:1 1831:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NN (Characterization))(JJ (tumor-suppressive))(NN (function))(NN (SOX6))(JJ (human))(NN (esophageal))(JJ (squamous))(NN (cell))(NN (carcinoma)))) |ET|  |BS| 8:C04 55:B01.050.150.900.649.801.400.112.400.400  |ES| 19:1 33:1 36:1 94:1 177:1 304:1 1064:1 1065:1 1066:1 1067:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (PRP$ (Our))(NN (finding)))(VP (VBP (suggest))(SBAR (S (NP (NN (JNK/PTEN))(NN (NF-kappaB/PTEN))(NN (pathway)))(VP (VBP (play))(NP (JJ (critical))(NP (NN (role))(JJ (normal))(NP (JJ (intestinal))(NN (homeostasis))(NN (colon))(NN (carcinogenesis)))))))))) |ET|  |BS| 15:F01.829.316.616 33:C04.697.098 46:A03.556.124.526.356 47:A03.556.124 79:I03.450.642.693 152:G07.700.345 210:D12.776.260.600  |ES| 19:1 31:1 109:1 113:1 118:1 207:1 238:1 383:1 500:1 658:1 796:1 825:1 927:1 2145:1 2146:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NN (Antitumor))(NN (function))(NN (microRNA-122))(JJ (hepatocellular))(NN (carcinoma)))) |ET|  |BS| 104:C04.557.470.200.025.255 184:D13.150.650.319  |ES| 19:1 33:1 303:1 304:1 1856:1 1857:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (HNF4alpha))(NN (Cdx2)))(ADVP (RB (also)))(VP (VBD (exhibited))(NP (JJ (comparable))(VBN (deregulated))(NN (pattern))(JJ (human))(NN (CRC))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 55:B01.050.150.900.649.801.400.112.400.400 175:J01.897.280.500.269  |ES| 5:1 19:1 36:1 123:1 213:1 245:1 260:1 609:1 1964:1 1965:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (VP (JJ (BCL2-like))(NP (NP (CD (11))(NN (intron))(CD (2))(NN (deletion))(NN (polymorphism)))(VP (VBN (associated))(NP (JJ (non-small))(NN (cell))(NN (lung))(NN (cancer))(NN (risk))(NN (prognosis))))))) |ET|  |BS| 54:G05.360.340.024.340.375.500.791.150 61:E05.318.740.600.800 110:C04.588.894.797.520.109.220.249 163:E01.789 305:G05.360.340.024.220.400 306:G05.355.600.800 307:G05.365.795  |ES| 18:1 19:1 94:1 148:1 169:1 171:1 328:1 544:1 694:1 1056:1 1057:1 1058:1 1059:1 1060:1  |EV| 
-3.5992609608395298437244491651654  |BT| (S (ADVP (RB (Here)))(, (,))(VP (VBD (investigated))(NP (NP (NN (cell))(NN (death))(NN (signaling))(NN (mechanism)))(VP (VBD (induced))(NP (NN (PGG))(JJ (human))(NN (prostate))(NN (cancer))(NN (cell))(JJ (different))(NN (p53))(JJ (functional))(NN (status))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 41:A11 55:B01.050.150.900.649.801.400.112.400.400 69:G02.111.087.800 133:D01.248.497.158.685.750.744.600 134:G04.299.139 135:C23.550.260  |ES| 2:1 12:1 18:1 19:1 36:1 77:1 94:1 162:1 195:1 400:1 403:1 411:1 412:1 413:1 414:1 415:1 416:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (JJ (Epigenetic))(NN (inactivation))(JJ (paired))(NN (box))(NN (gene))(CD (5)))(, (,))(NP (JJ (novel))(NN (tumor))(NN (suppressor))(NN (gene)))(, (,))(NP (NP (JJ (direct))(NN (upregulation))(NN (p53)))(NP (VBN (associated))(NN (prognosis))(JJ (gastric))(NN (cancer))(NN (patient))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 42:G05.355.315.203.374 50:M01.643 163:E01.789 206:G05.360.340.024.340.375.249 249:G05.355.315.800 259:D12.776.395.240.150.500 339:G02.111.087.880  |ES| 2:1 7:1 9:1 12:1 18:1 19:1 86:1 120:1 169:1 544:1 578:1 700:1 790:1 891:1 1126:1 1201:1 1314:1 1891:1 1918:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NNS (Aberrations))(NP (NP (NP (JJ (fragile))(NN (histidine))(NN (triad)))(PRN (-LRB- (-LRB-))(NP (NN (FHIT)))(-RRB- (-RRB-))))(NN (gene))(JJ (idiopathic))(JJ (pulmonary))(NN (fibrosis)))) |ET|  |BS| 6:G05.360.340.024.340 276:C08.381.483.487.500 277:D12.125.072.329  |ES| 9:1 10:1 14:1 19:1 942:1 943:1 944:1 945:1 946:1 947:1 948:1 949:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (JJ (Acute))(NN (ablation))(NN (GSK3beta))(JJ (colorectal))(NN (cancer))(NN (cell)))(VP (VBZ (activates))(NP (JJ (p53-dependent))(NN (apoptosis)))))(SBAR (S (VP (VBZ (antagonizes))(NP (NN (tumor))(NN (growth)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 8:C04 39:G04.299.139.160 41:A11 45:G07.700.320.249  |ES| 7:1 17:1 18:1 19:1 88:1 89:1 91:1 94:1 102:1 104:1 239:1 301:1 794:1 1893:1 1894:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NP (ADJP (RB (Little))(VBN (known)))(JJ (biological))(NN (significance))(NN (ELK1)))(, (,))(NP (JJ (transcriptional))(NN (factor))))(VP (VBZ (activates))(NP (NP (JJ (downstream))(NN (target)))(PP (VBG (including))(NP (NP (NN (c-fos))(NN (proto-oncogene)))(, (,))(NP (NN (bladder))(NN (cancer)))))))) |ET|  |BS| 165:G05.360.340.024.340.375.500.791.330 166:D12.776.930 167:H01.158.273  |ES| 2:1 18:1 19:1 160:1 185:1 301:1 440:1 555:1 556:1 557:1 558:1 559:1 560:1 561:1 562:1 563:1 564:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Sil))(NN (gene))(NN (expression))(NN (lung))(NN (cancer)))(VP (VBD (correlated))(NP (NN (expression))(JJ (several))(NN (kinetochore))(NN (check-point))(NN (gene))(JJ (histopathologic))(JJ (mitotic))(NN (index))))) |ET|  |BS| 155:G05.355.310 211:A11.284.430.106.279.345.190.160.165.500 212:E01.370.225.500.385.500  |ES| 9:1 18:1 19:1 115:1 262:1 328:1 446:1 716:1 717:1 718:1 719:1 720:1 721:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (NN (Reduction))(NN (ING1b))(NN (gene))(NN (expression)))(VP (VBN (associated))(VP (VBD (reduced))(NP (NN (p21))(NN (bax))(NN (gene))(NN (expression))(NNS (NSCLCs))))))) |ET|  |BS| 110:C04.588.894.797.520.109.220.249 155:G05.355.310 342:D12.644.360.075.718.400  |ES| 9:1 19:1 104:1 115:1 169:1 239:1 452:1 1133:1 1134:1 1135:1 1136:1 1137:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (Germ-line))(NN (mutation))(NN (APC))(NN (gene)))(VP (NN (cause))(SBAR (S (NP (NP (JJ (adenomatous))(NN (polyposis))(NN (coli))(PRN (-LRB- (-LRB-))(NP (NN (APC)))(-RRB- (-RRB-))))(, (,))(NP (NN (syndrome))(NN (patient))))(VP (VBP (develop))(NP (CD (hundred))(CD (thousand))(JJ (precancerous))(JJ (adenomatous))(JJ (colorectal))(NN (polyp)))))))) |ET|  |BS| 3:C04.557.470.035.215.100 6:G05.360.340.024.340 21:G05.360.340.024.340.375.249.050 50:M01.643 341:C04.834 551:C04.557.470.035.215 552:G05.365.590.350 553:C23.550.288.500  |ES| 2:1 9:1 10:1 11:1 14:1 17:1 19:1 34:1 57:1 58:1 59:1 120:1 647:1 648:1 1130:1 1779:1 1939:1 1940:1 1941:1 1942:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NNS (Mutations))(NP (NP (NN (APC))(NN (gene))(NN (play))(JJ (critical))(NN (role)))(JJ (sporadic))(JJ (familial))(NN (form))(JJ (colorectal))(NN (cancer)))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 15:F01.829.316.616 18:G05.365.590 21:G05.360.340.024.340.375.249.050 44:F01.829.263 79:I03.450.642.693 189:V02.460  |ES| 9:1 11:1 17:1 18:1 19:1 31:1 238:1 630:1 725:1 825:1 854:1 1410:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (CRC))(NN (xenograft)))(VP (VBD (differed))(NP (NP (NP (NP (NN (p53))(NN (status)))(PRN (-LRB- (-LRB-))(NP (JJ (wt))(NN (muf)))(-RRB- (-RRB-))))(NN (microsatellite))(NN (instability))(NN (phenotype)))(PRN (-LRB- (-LRB-))(NP (NP (NN (MSI)))(CC (+))(NP (JJ (altered))))(-RRB- (-RRB-)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 80:G05.695 92:E04.936.764 93:A01.941.875 538:C23.550.362.590  |ES| 10:1 12:1 14:1 19:1 236:1 245:1 265:1 416:1 693:1 1299:1 1332:1 1901:1 1902:1 1903:1 1904:1  |EV| 
-0.54914453136096597063442459329963  |BT| (NP (NP (NP (NP (JJ (Altered))(NN (expression))(JJ (human))(NN (enhancer))(NN (filamentation))(CD (1)))(PRN (-LRB- (-LRB-))(NP (NP (NN (HEF1)))(: (;))(NP (ADJP (RB (also))(VBN (known)))(NN (NEDD9))(NN (Cas-L))))(-RRB- (-RRB-))))(NP (VBN (implicated))(NN (progression))(NN (melanoma))(, (,))(NN (breast))(, (,))(NN (CRC))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 10:A01.236 15:F01.829.316.616 16:C23.550.291.656 32:C04.697.098.500 33:C04.697.098 55:B01.050.150.900.649.801.400.112.400.400 142:I01.880.604 239:F02.463.188.357 282:C04.557.465.625.650.510  |ES| 2:1 5:1 10:1 14:1 19:1 23:1 31:1 36:1 48:1 78:1 98:1 115:1 217:1 245:1 433:1 438:1 556:1 889:1 971:1 972:1 973:1 974:1 975:1 976:1 977:1 978:1 979:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NP (NP (CD (Fifty-four)))(PRN (-LRB- (-LRB-))(NP (CD (73))(NN (%)))(-RRB- (-RRB-))))(NP (NP (CD (74))(NN (lesion))(NNS (metaplasias))(JJ (bronchiolar))(NN (epithelium)))(VP (VBN (obtained))(NP (NP (JJ (IPF))(NN (patient))(NN (lung))(NN (carcinoma))(CD (8)))(PRN (-LRB- (-LRB-))(NP (CD (17))(NN (%)))(-RRB- (-RRB-))))(NP (NP (CD (46))(NN (sample)))(VP (VBN (obtained))(NP (NP (JJ (IPF))(NN (patient)))(PP (IN (without))(NP (NN (lung))(NN (carcinoma))))))))))(VP (VBD (showed))(NP (NP (NNP (LOH))(NNP (FHIT))(NN (gene)))(PRN (-LRB- (-LRB-))(S (NP (NN (P)))(VP (JJR (<))(NP (CD (0.0001)))))(-RRB- (-RRB-)))))) |ET|  |BS| 6:G05.360.340.024.340 48:C23.550.589 50:M01.643 62:A10.272 182:A04.411 265:C04.557.470.200 276:C08.381.483.487.500 290:G05.365.590.029.530 337:C08.381.765 365:A04.411.125.500  |ES| 9:1 10:1 14:1 19:1 120:1 132:1 173:1 304:1 311:1 312:1 328:1 369:1 575:1 781:1 835:1 930:1 946:1 1004:1 1122:1 1131:1 1195:1 1220:1 1221:1 1222:1 1223:1 1224:1 1225:1 1226:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (MiR-145)))(VP (VBZ (modulates))(NP (JJ (multiple))(NN (component))(JJ (insulin-like))(NN (growth))(NN (factor))(NN (pathway))(JJ (hepatocellular))(NN (carcinoma))))) |ET|  |BS| 104:C04.557.470.200.025.255 581:D12.644.276.937  |ES| 19:1 102:1 185:1 303:1 304:1 383:1 606:1 649:1 1021:1 2092:1 2093:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NN (loss))(NN (PTEN))(NN (dysregulation)))(VP (VBG (transforming))(NP (NP (NN (growth))(NN (factor))(NN (beta))(NN (signaling)))(VP (VBN (considered))(S (NP (JJ (involved))(NN (rat))(NN (hepatocarcinogenesis))(JJ (early))(NN (stage)))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 69:G02.111.087.800 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 503:D12.644.276.374.687  |ES| 2:1 19:1 32:1 102:1 185:1 195:1 244:1 774:1 849:1 900:1 1061:1 1128:1 1129:1 1202:1 1284:1 1772:1 1936:1 1972:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (NAC1)))(VP (VBZ (modulates))(NP (NP (NN (sensitivity))(JJ (ovarian))(NN (cancer))(NN (cell))(NN (cisplatin)))(VP (VBG (altering))(NP (JJ (HMGB1-mediated))(JJ (autophagic))(NN (response))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 41:A11 390:G04.299.139.399 498:D01.210.375 585:D12.644.276.087.371  |ES| 18:1 19:1 94:1 494:1 606:1 607:1 1761:1 1763:1 2137:1 2138:1 2139:1 2140:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NN (EGFR))(NN (gene))(NN (mutation))(NN (ALK))(NN (gene))(NN (fusion))(JJ (well-characterized))(JJ (molecular))(NN (target))(NN (NSCLC)))) |ET|  |BS| 18:G05.365.590 110:C04.588.894.797.520.109.220.249 358:G05.360.340.024.340.375.500.791.295.300 359:G05.355.760.385  |ES| 9:1 19:1 34:1 160:1 161:1 187:1 329:1 936:1 962:1 1200:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(NP (NP (NN (Jab1))(NN (expression)))(, (,))(NP (ADVP (RB (well)))(NP (NP (NN (p27)))(PRN (-LRB- (-LRB-))(NP (NN (Kip1)))(-RRB- (-RRB-))))(NN (upregulation)))(, (,))(NP (JJ (evident))(JJ (early))(NN (stage))(NN (hepatocarcinogenesis)))(, (,))(S (VP (VBG (suggesting))(SBAR (S (NP (NN (Jab1)))(VP (MD (could))(NP (JJ (diagnostic))(NN (marker))(NN (treatment))(NN (target))(JJ (precancerous))(NN (lesion))(JJ (early))(NNS (HCCs)))))))))) |ET|  |BS| 52:E02 104:C04.557.470.200.025.255 158:D23.101 249:G05.355.315.800 263:E01 338:D12.644.360.225.600 339:G02.111.087.880 340:C17.800.229.400 341:C04.834  |ES| 2:1 10:1 14:1 19:1 104:1 115:1 160:1 239:1 534:1 546:1 787:1 900:1 903:1 908:1 1009:1 1123:1 1124:1 1125:1 1126:1 1127:1 1128:1 1129:1 1130:1 1131:1 1132:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (DT (The))(NN (Tg737))(NN (gene)))(VP (VBD (investigated))(NP (JJ (gross))(NN (alteration))(NN (series))(NN (rodent/human))(NN (liver))(NN (tumor))(JJ (human))(JJ (tumorigenic))(NN (cell))(NN (line))))) |ET|  |BS| 6:G05.360.340.024.340 55:B01.050.150.900.649.801.400.112.400.400 94:A11.251.210 514:B01.050.150.900.649.865 515:C04.588.274.623  |ES| 7:1 9:1 19:1 36:1 94:1 264:1 403:1 691:1 836:1 951:1 1805:1 1806:1 1807:1 1808:1 1809:1  |EV| 
-4.1391962676862590342352632433176  |BT| (S (NP (NN (Mir-660)))(VP (VBD (downregulated))(SBAR (S (NP (NN (lung))(NN (cancer))(NN (patient))(NN (replacement)))(VP (VBZ (inhibits))(NP (NP (NN (lung))(NN (tumorigenesis)))(VP (VBG (targeting))(NP (NN (MDM2-p53))(NN (interaction)))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 32:C04.697.098.500 33:C04.697.098 50:M01.643 122:C14.280.383 181:E04.936.494 182:A04.411  |ES| 18:1 19:1 78:1 120:1 328:1 426:1 613:1 614:1 615:1 616:1 617:1 618:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (YY1)))(VP (VBZ (promotes))(NP (NP (NN (colon))(NN (cancer))(NN (growth)))(VP (VBG (inhibiting))(NP (NP (NN (p53)))(S (VP (VBG (promoting))(NP (NN (Wnt))(NN (signaling))(NN (pathway))(NN (serf))(JJ (independent))(JJ (prognostic))(NN (biomarker))(NN (CRC))(NN (patient)))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 45:G07.700.320.249 50:M01.643 122:C14.280.383 147:G02.149.115.800.925 158:D23.101 258:D12.776.260.235.875  |ES| 12:1 18:1 19:1 102:1 113:1 120:1 195:1 245:1 298:1 383:1 877:1 879:1 880:1 881:1 882:1 883:1 884:1 885:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (Number))(NN (size))(JJ (intestinal))(NN (tumor)))(ADVP (RB (significantly)))(VP (VBD (increased))(NP (NN (mouse))(NN (bearing))(JJ (adenomatous))(NN (polyposis))(NN (coli))(-LRB- (-LRB-))(NN (APC))(-RRB- (-RRB-))(NN (PTEN))(NN (mutation))))) |ET|  |BS| 3:C04.557.470.035.215.100 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 21:G05.360.340.024.340.375.249.050 102:C04.588.274.476.411 455:B01.050.150.900.649.147.890  |ES| 7:1 10:1 11:1 14:1 19:1 34:1 47:1 52:1 57:1 58:1 59:1 109:1 124:1 1584:1 1936:1 2141:1 2142:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (Inactivation))(NN (APC))(NN (gene)))(VP (VBN (considered))(S (VP (VBG (initiating))(NP (NN (event))(JJ (human))(JJ (colorectal))(NN (cancer))))))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 42:G05.355.315.203.374 55:B01.050.150.900.649.801.400.112.400.400  |ES| 9:1 11:1 17:1 18:1 19:1 36:1 205:1 1061:1 2018:1 2019:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (CDX2))(NN (expression)))(VP (ADVP (RB (significantly)))(VBD (decreased))(NP (NP (JJ (incomplete))(JJ (intestinal))(NN (metaplasia)))(, (,))(NP (VBP (express))(NP (NP (JJ (gastric))(NN (mucin)))(PRN (-LRB- (-LRB-))(NP (NN (MUC5AC))(NN (MUC6)))(-RRB- (-RRB-))))(JJ (intestinal))(NP (NP (NN (mucin)))(PRN (-LRB- (-LRB-))(NP (NN (MUC2)))(-RRB- (-RRB-)))))(, (,)))(VP (VBD (compared))(NP (JJ (complete))(JJ (intestinal))(NN (metaplasia))))(, (,))(S (VP (VBP (express))(NP (NP (JJ (intestinal))(NN (mucin)))(PRN (-LRB- (-LRB-))(NP (NN (MUC2)))(-RRB- (-RRB-)))))))) |ET|  |BS| 47:A03.556.124 48:C23.550.589 71:D12.776.395.560.631 72:D12.776.395.560.631.100  |ES| 2:1 10:1 14:1 19:1 50:1 86:1 108:1 109:1 110:1 114:1 115:1 124:1 172:1 202:1 208:1 209:1 210:1 211:1 212:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NP (CD (One))(JJ (common))(JJ (rate-limiting))(NN (mutation)))(JJ (human))(NN (CRC)))(VP (VBZ (occurs))(NP (JJ (adenomatous))(NN (polyposis))(NN (coli))(-LRB- (-LRB-))(NN (APC))(-RRB- (-RRB-))(NN (gene))))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 21:G05.360.340.024.340.375.249.050 55:B01.050.150.900.649.801.400.112.400.400 194:G05.355.044.250.750  |ES| 9:1 10:1 11:1 14:1 19:1 34:1 36:1 57:1 58:1 59:1 245:1 654:1 655:1 656:1 657:1  |EV| 
-1.2654980607019297167425975203514  |BT| (S (NP (NN (Cyclooxygenase-2))(NN (inhibitor)))(VP (VBP (down-regulate))(NP (NN (osteopontin))(NN (Nr4A2-new))(JJ (therapeutic))(NN (target))(JJ (colorectal))(NN (cancer))))) |ET|  |BS| 4:C04.588.274.476.411.307 52:E02 349:D27.505.519.389.310.500 350:D12.644.276.374.625 351:A17.360  |ES| 17:1 18:1 19:1 160:1 380:1 541:1 1158:1 1159:1 1160:1 1161:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Microsomal))(NN (prostaglandin))(NN (E))(NN (synthase-1)))(VP (VBZ (promotes))(NP (NN (hepatocarcinogenesis))(NN (activation))(JJ (novel))(NN (EGR1/beta-catenin))(NN (signaling))(NN (axis))))) |ET|  |BS| 23:D12.776.091.249 69:G02.111.087.800 259:D12.776.395.240.150.500 579:A02.835.232.834.151.383 580:D12.776.260.158.500  |ES| 19:1 195:1 225:1 298:1 891:1 900:1 2083:1 2084:1 2085:1 2086:1 2088:1 2089:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NN (MiR-7))(JJ (novel))(NN (miRNA))(NN (tumor))(JJ (suppressive))(NN (function))(NN (colon))(NN (cancer)))(VP (VBG (targeting))(NP (JJ (oncogenic))(NN (YY1))))) |ET|  |BS| 8:C04 184:D13.150.650.319 258:D12.776.260.235.875 259:D12.776.395.240.150.500 279:D27.888.569.100  |ES| 2:1 7:1 18:1 19:1 33:1 113:1 244:1 616:1 840:1 879:1 891:1 953:1 1284:1 1973:1 1974:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (HOX))(NN (gene)))(ADVP (RB (frequently)))(VP (VBN (dysregulated))(NP (NP (JJ (human))(NN (leukaemia))(NN (gene))(NN (rearrangement))(JJ (mixed))(NN (lineage))(NN (leukaemia)))(PRN (-LRB- (-LRB-))(NP (NN (MLL)))(-RRB- (-RRB-))))(NP (NN (partner))(NN (gene))))) |ET|  |BS| 6:G05.360.340.024.340 55:B01.050.150.900.649.801.400.112.400.400 229:G05.360.340.024.340.230.500 361:C04.557.337 373:G05.355.330  |ES| 9:1 10:1 14:1 19:1 36:1 698:1 1204:1 1207:1 1259:1 1260:1 1261:1 1262:1 1263:1 1264:1  |EV| 
-5.1698483124001830546490054985043  |BT| (FRAG (NP (S (NP (NP (NNS (Mice))(NN (mutation))(NN (mismatch))(NN (repair))(NN (gene)))(, (,))(NP (NN (Msh2))(NN (Mlh1)))(, (,)))(VP (VBP (exhibit))(S (NP (NN (mismatch))(NN (repair))(NN (defect)))(VP (VBN (predisposed))(S (VP (VBG (developing))(NP (JJ (gastrointestinal))(NN (cancer)))))))))(, (,))(NN (lymphoma))(NN (tumor))(NN (organ))(NN (system)))) |ET|  |BS| 6:G05.360.340.024.340 8:C04 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 174:G02.111.087.219.220 175:J01.897.280.500.269 176:C04.557.386  |ES| 2:1 7:1 9:1 18:1 19:1 34:1 183:1 513:1 583:1 584:1 585:1 586:1 587:1 588:1 589:1 590:1 591:1 592:1 593:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NN (Regulation))(NN (tumor))(NN (suppressor))(NN (homeogene))(NN (Cdx2))(NN (HNF4alpha))(JJ (intestinal))(NN (cancer)))) |ET|  |BS| 38:Z01.058.290.120.180 40:Z01.542.248.700 101:C04.588.274.476.411 142:I01.880.604 206:G05.360.340.024.340.375.249  |ES| 7:1 18:1 19:1 109:1 123:1 213:1 699:1 700:1 701:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NP (NP (NN (Peroxisome))(JJ (proliferator-activated))(NN (receptor-gamma1)))(PRN (-LRB- (-LRB-))(NP (NN (PPARgamma1)))(-RRB- (-RRB-))))(JJ (important))(NN (transcription))(NN (factor)))(VP (VBN (involved))(NP (NN (atherosclerosis))(NN (progression))))) |ET|  |BS| 16:C23.550.291.656 166:D12.776.930 511:C14.907.137.126.307 512:D12.776.826.239 513:C14.907.137.126  |ES| 10:1 14:1 19:1 48:1 185:1 487:1 774:1 902:1 1800:1 1801:1 1802:1 1803:1 1804:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (miR-490-3p)))(VP (VBD (exerted))(NP (NP (NN (growth)))(: (-))(NP (NP (JJ (metastasis-suppressive))(NN (effect))(JJ (gastric))(NN (cancer))(NN (cell)))(VP (ADVP (RB (directly)))(VBG (targeting))(NP (NP (NN (SMARCD1)))(, (,))(NP (NP (NN (SWItch/Sucrose))(NN (NonFermentable)))(PRN (-LRB- (-LRB-))(NP (NN (SWI/SNF)))(-RRB- (-RRB-))))(NP (NN (chromatin))(NN (remodeling))(NN (complex))(NN (subunit))))))))) |ET|  |BS| 41:A11 45:G07.700.320.249 113:C04.697.650 582:D09.698.629.305.770 583:D12.776.813  |ES| 2:1 10:1 14:1 18:1 19:1 75:1 86:1 94:1 608:1 616:1 621:1 695:1 1346:1 2102:1 2103:1 2104:1 2105:1 2106:1 2107:1 2108:1 2109:1 2110:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NP (DT (A))(JJ (novel))(NN (GSK-3))(NN (beta-C/EBP))(JJ (alpha-miR-122-insulin-like))(NN (growth))(NN (factor))(CD (1))(NN (receptor))(JJ (regulatory))(NN (circuitry)))(NP (JJ (human))(JJ (hepatocellular))(NN (carcinoma))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 259:D12.776.395.240.150.500 518:D08.811.913.696.620.682.725.400.185 519:D05.500.117.875  |ES| 19:1 36:1 69:1 98:1 102:1 185:1 186:1 303:1 304:1 891:1 1814:1 1815:1 1816:1 1817:1 1818:1  |EV| 
-4.6455240471285890180297428742051  |BT| (S (NP (NN (Western))(NN (blot)))(VP (VBD (revealed))(NP (NP (NN (overexpression))(NN (beta-catenin)))(, (,))(NP (NP (NN (c-Myc)))(, (,))(NP (NN (cyclin))(NN (D1)))(, (,))(NP (JJ (inducible))(JJ (nitric))(NN (oxide))(NN (synthase)))(NP (NN (cyclooxygenase-2))(NN (colon))(NN (tumor))(NN (sample))))))) |ET|  |BS| 22:D08.811.682.664.500.772.500 23:D12.776.091.249 24:D08.811.600.720.750 51:C04.588.274.476.411.307.180 215:D12.644.360.262.150.100 255:E05.196.401.143  |ES| 2:1 7:1 19:1 60:1 61:1 63:1 64:1 65:1 66:1 113:1 152:1 275:1 743:1 744:1 824:1 835:1 872:1 873:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NNS (Mutations)))(NP (NP (NP (JJ (human))(NN (DNA))(NN (mismatch))(NN (repair)))(PRN (-LRB- (-LRB-))(NP (NN (MMR)))(-RRB- (-RRB-))))(NP (NP (NP (NN (gene))(NN (MLH1))(VBN (associated))(JJ (hereditary))(JJ (nonpolyposis))(JJ (colorectal))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NP (NNP (Lynch))(NN (syndrome)))(, (,))(NP (NN (HNPCC))))(-RRB- (-RRB-))))(NP (JJ (significant))(NN (proportion))(JJ (sporadic))(JJ (colorectal))(NN (cancer)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 18:G05.365.590 55:B01.050.150.900.649.801.400.112.400.400 174:G02.111.087.219.220 524:C04.588.274.476.411.307.190  |ES| 2:1 9:1 10:1 14:1 17:1 18:1 19:1 36:1 135:1 169:1 513:1 584:1 666:1 723:1 725:1 1294:1 1410:1 1845:1 1846:1 1940:1 2134:1 2135:1 2136:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (JJ (current))(NN (report))))(, (,))(VBN (used))(S (NP (NN (DLD-1))(JJ (colorectal))(NN (cancer))(NN (cell)))(ADVP (RB (stably)))(NP (VBN (transfected))(NP (NN (POX))(NN (gene))(NN (control))(JJ (tetracycline-inducible))(NN (promoter))))(VP (VBD (found))(SBAR (S (NP (CD (three))(NN (pathway))(NN (cross))(NN (talk)))(VP (VBD (downregulated))(NP (NP (NN (POX)))(: (:))(NP (NP (NP (NP (NN (cyclooxygenase-2)))(PRN (-LRB- (-LRB-))(NP (NN (COX-2)))(-RRB- (-RRB-))))(NN (pathway)))(, (,))(NP (NP (NP (JJ (epidermal))(NN (growth))(NN (factor))(NN (receptor)))(PRN (-LRB- (-LRB-))(NP (NN (EGFR)))(-RRB- (-RRB-))))(NN (pathway))(NN (Wnt/beta-catenin))(NN (pathway))))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 23:D12.776.091.249 24:D08.811.600.720.750 41:A11 64:D08.811.913.696.620.682.725.400.009.300 146:D02.455.426.559.847.562.900.875 147:G02.149.115.800.925 148:G12.425.143.281  |ES| 2:1 9:1 10:1 14:1 17:1 18:1 19:1 37:1 61:1 76:1 83:1 94:1 102:1 104:1 175:1 184:1 185:1 186:1 187:1 244:1 289:1 302:1 383:1 417:1 426:1 476:1 477:1 478:1 479:1 480:1 481:1 482:1 483:1 484:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NNP (Integrated))(JJ (transcriptomic))(JJ (genomic))(NN (analysis)))(VP (VBN (defined))(S (NP (NP (JJ (distinct))(NN (superenhancer))(NN (CIMP)))(CC (+))(NP (NN (colon))(NN (cancer))))(VP (VBZ (regulates))(NP (NN (cMYC))(NN (transcription))))))) |ET|  |BS| 209:G02.111.087.847 268:H01.158.273.180.350 269:G05.360.340  |ES| 18:1 19:1 113:1 487:1 603:1 661:1 680:1 910:1 2024:1 2025:1 2026:1 2027:1 2028:1 2029:1  |EV| 
-0.33344501635974665987305343151093  |BT| (S (S (S (VP (TO (To))(VP (VB (understand))(NP (NN (miR-141))))))(VP (VBZ (mediates))(NP (NN (phenotype))(JJ (pancreatic))(NN (cancer))(NN (cell)))))(S (, (,))(NP (NNS (bioinformatics))(NN (tool)))(VP (VBN (used))(VP (VBP (identify))(NP (NN (MAP4K4))(JJ (potential))(NN (target))(NN (miR-141))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 41:A11 80:G05.695 239:F02.463.188.357 240:H01.158.273.180  |ES| 2:1 18:1 19:1 94:1 160:1 236:1 463:1 465:1 467:1 476:1 755:1 827:1 828:1 829:1 830:1 831:1 832:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NP (JJ (Antisense))(NNS (oligodeoxynucleotides))(JJ (human))(NN (superoxide))(NN (dismutase))(CD (2)))(CC (and/or))(NP (JJ (ectopic))(NN (bcl-2))(NN (overexpression))))(VP (VBD (avoided))(NP (NP (NNS (polyphenols)))(SBAR (S (NP (JJ (chemoradiotherapy-induced))(JJ (colorectal))(NN (cancer))(NN (elimination)))(VP (VBD (showed))(NP (NP (JJ (mangano-type))(NN (superoxide))(NN (dismutase))(NN (Bcl-2))(JJ (key))(NN (target))(JJ (molecular))(NN (mechanism)))(VP (VBN (activated))(NP (JJ (combined))(NN (application))(NN (t-PTER))(NNP (QUER))))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 54:G05.360.340.024.340.375.500.791.150 55:B01.050.150.900.649.801.400.112.400.400 56:D02.455.426.559.389.657.715 57:D13.695.578.424.450 58:D08.811.682.881 59:E02.186.079  |ES| 17:1 18:1 19:1 36:1 132:1 144:1 145:1 146:1 147:1 148:1 149:1 150:1 151:1 152:1 153:1 154:1 155:1 156:1 157:1 158:1 159:1 160:1 161:1 162:1 163:1 164:1 165:1 166:1 167:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NNS (Mice)))(NP (JJ (heterozygous))(JJ (dominant))(NN (Min))(NN (mutation))(NN (Apc))(NN (gene)))(VP (VBP (develop))(NP (JJ (multiple))(JJ (intestinal))(NN (neoplasia))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 21:G05.360.340.024.340.375.249.050 102:C04.588.274.476.411 157:G05.380.383  |ES| 9:1 19:1 34:1 109:1 280:1 583:1 640:1 648:1 649:1 650:1 786:1 2049:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NNS (Mutations))(NP (NP (NN (APC))(NN (gene))(JJ (responsible))(JJ (familial))(JJ (adenomatous))(NN (polyposis)))(PRN (-LRB- (-LRB-))(NP (NN (FAP)))(-RRB- (-RRB-))))(NN (majority))(JJ (sporadic))(JJ (colorectal))(NN (cancer)))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 18:G05.365.590 21:G05.360.340.024.340.375.249.050  |ES| 9:1 10:1 11:1 14:1 17:1 18:1 19:1 57:1 58:1 198:1 725:1 854:1 1410:1 2132:1 2133:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (CRC)))(VP (VBD (initiated))(NP (NP (NN (mutation))(NN (tumor))(NN (suppressor))(NN (gene)))(, (,))(NP (JJ (adenomatous))(NN (polyposis))(NN (coli))(-LRB- (-LRB-))(NN (APC))(-RRB- (-RRB-))))(, (,))(NP (NN (beta-catenin))(NN (gene))))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 18:G05.365.590 21:G05.360.340.024.340.375.249.050 23:D12.776.091.249 206:G05.360.340.024.340.375.249  |ES| 2:1 7:1 9:1 10:1 11:1 14:1 19:1 34:1 57:1 58:1 59:1 60:1 245:1 700:1 1900:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (JJ (Epigenetic))(NN (dysregulation))(JJ (leukaemic))(NN (HOX))(NN (code))(JJ (MLL-rearranged))(NN (leukaemia))(NN (mouse))(NN (model)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 360:N04.452.758.708.200.400.500 361:C04.557.337  |ES| 19:1 52:1 72:1 1201:1 1202:1 1203:1 1204:1 1205:1 1206:1 1207:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NP (DT (The))(JJ (adenomatous))(NN (polyposis))(NN (coli))(-LRB- (-LRB-))(NN (APC))(-RRB- (-RRB-))(NN (gene))(NN (product)))(NP (VBN (mutated))(JJ (vast))(NN (majority))(JJ (human))(JJ (colorectal))(NN (cancer))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 219:G05.360.340.024.340.375.249.320 220:D05.500.117.249  |ES| 9:1 10:1 11:1 14:1 17:1 18:1 19:1 36:1 57:1 58:1 59:1 198:1 229:1 675:1 691:1 752:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (DT (A))(JJ (previous))(NN (investigation)))(VP (VBD (indicated))(NP (NP (NN (ATA))(JJ (effective))(VBG (inhibiting))(NN (growth))(NN (breast))(NN (cancer)))(NP (RB (especially))(NN (cell))(NN (HER2))(NN (overexpression)))))) |ET|  |BS| 41:A11 45:G07.700.320.249 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 122:C14.280.383 225:E05.337 520:C10.228.140.252.190.530.060  |ES| 18:1 19:1 23:1 69:1 94:1 102:1 152:1 188:1 345:1 880:1 1497:1 1541:1 1639:1 1819:1 1820:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Analysis))(NN (TP53))(NN (CTNNB1))(NN (gene))(NN (mutation)))(NP (NNP (HG))(NN (component))(NNS (MASCs)))(ADVP (RB (well)))(NP (NN (detection))(NN (copy))(NN (number))(NN (aberration))(NN (EGFR))(NN (CCND1))(NN (gene)))(VP (VBP (harbor))(NP (NN (abnormality))))) |ET|  |BS| 6:G05.360.340.024.340 18:G05.365.590 23:D12.776.091.249 254:C16.131 293:D01.268.556.504 294:G05.360.340.024.340.137  |ES| 9:1 19:1 34:1 119:1 187:1 646:1 787:1 963:1 1018:1 1019:1 1020:1 1021:1 1022:1 1023:1 1024:1 1025:1 1026:1 1027:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (DT (A))(NN (Cox))(JJ (proportional))(NN (hazard))(NN (model)))(VP (VBD (showed))(NP (NP (NN (IFITM3))(NN (expression))(JJ (independent))(JJ (prognostic))(NN (factor)))(NP (JJ (disease-free))(NN (survival))(NN (patient))(NN (colon))(NN (cancer)))))) |ET|  |BS| 12:Z01.542.049 50:M01.643 516:E05.318.740.500.700 517:E01.789.200  |ES| 18:1 19:1 69:1 72:1 113:1 115:1 120:1 132:1 185:1 274:1 696:1 883:1 884:1 1810:1 1811:1 1812:1 1813:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (aggregate))))(, (,))(VP (VBP (conclude))(NP (NP (NP (NN (Let-7))(NN (depletion))(NN (drive))(NN (stem))(NN (cell))(NN (phenotype)))(NN (development))(JJ (intestinal))(NN (cancer)))(, (,))(PP (ADVP (RB (primarily)))(IN (via))(NP (NN (Hmga2))))))) |ET|  |BS| 66:F01.658.293 80:G05.695 101:C04.588.274.476.411 283:D12.776.260.312.937 308:A11.872 557:D02.241.081.069.600.150  |ES| 2:1 18:1 19:1 35:1 94:1 109:1 181:1 236:1 244:1 596:1 1106:1 1613:1 1967:1 1968:1 1969:1 1970:1 1971:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (ADVP (RB (Furthermore)))(NP (NP (NN (strategy)))(VP (VBN (designed))(VP (VB (restore))(NP (NN (expression))(NN (PTEN))))))(VP (MD (may))(S (VP (VBG (promising))(NP (NP (NN (therapy)))(VP (VBG (preventing))(NP (NN (HCV))(JJ (dependent))(NN (hepatocarcinogenesis))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 550:B04.450.410  |ES| 19:1 115:1 130:1 321:1 334:1 491:1 900:1 1114:1 1517:1 1683:1 1935:1 1936:1 1937:1 1938:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (Hepatocarcinogenesis)))(VP (VBD (induced))(NP (NN (diethylnitrosamine))(JJ (hepatic))(NN (deletion))(NN (PTEN))))) |ET|  |BS| 306:G05.355.600.800 554:D02.654.442.200  |ES| 19:1 412:1 838:1 1059:1 1936:1 1952:1 1959:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (PRP$ (Our))(JJ (recent))(NN (study)))(VP (VB (establish))(NP (JJ (oncogenic))(NN (role))(NP (NP (NNP (LSF))(JJ (Hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))))) |ET|  |BS| 12:Z01.542.049 15:F01.829.316.616 104:C04.557.470.200.025.255 279:D27.888.569.100  |ES| 10:1 14:1 19:1 31:1 131:1 220:1 304:1 441:1 658:1 659:1 953:1 2150:1 2151:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (DT (These))(NNS (data)))(VP (VP (VBP (provide))(NP (NN (evidence))(NN (Cdx2))(VP (VBZ (antagonizes))(NP (NN (process))(NN (tumor))(NN (cell))(NN (dissemination))))))(, (,))(VP (VBP (suggest))(SBAR (S (NP (NN (homeobox))(NN (gene)))(VP (MD (might))(VP (VB (represent))(NP (JJ (new))(JJ (therapeutic))(NN (target))(JJ (metastatic))(NN (spreading))(NN (colon))(NN (cancer)))))))))) |ET|  |BS| 8:C04 52:E02 229:G05.360.340.024.340.230.500 230:G04  |ES| 2:1 7:1 9:1 18:1 19:1 38:1 94:1 113:1 160:1 213:1 337:1 541:1 638:1 711:1 712:1 792:1 793:1 794:1 795:1 796:1 797:1 798:1 799:1 800:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (PRP$ (Our))(NN (result)))(VP (VB (identify))(NP (NP (NP (JJ (novel))(NN (candidate))(NN (mouse))(NN (gene)))(, (,))(NP (NN (Zfp277)))(, (,)))(SBAR (WHNP (WP$ (whose))(NN (expression))(NN (pattern)))(S (NP (JJ (compatible))(NN (role)))(VP (VBG (mediating))(NP (JJ (divergent))(NN (effect))(NN (Chrm3))(NN (Chrm1))(NN (gene))(NN (ablation))(JJ (murine))(JJ (intestinal))(NN (neoplasia)))))))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 15:F01.829.316.616 47:A03.556.124 102:C04.588.274.476.411 259:D12.776.395.240.150.500 537:G05.360.340.024.340.375  |ES| 2:1 9:1 19:1 31:1 52:1 75:1 91:1 101:1 104:1 109:1 115:1 239:1 260:1 627:1 640:1 658:1 761:1 832:1 891:1 919:1 1243:1 1895:1 1896:1 1897:1 1898:1 1899:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (ADVP (RB (However)))(, (,))(NP (NP (JJ (molecular))(NN (detail)))(VP (VBG (underlying))(NP (NP (NN (miR-146a))(JJ (mediated))(NN (regulation))(NN (target))(NN (gene))(JJ (precise))(JJ (biological))(NN (function))(NN (cancer)))(, (,))(NP (NP (RB (especially))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))))(VP (VBZ (remains))(ADJP (JJ (unclear))))) |ET|  |BS| 104:C04.557.470.200.025.255 140:G05.355.315 141:G16.100  |ES| 2:1 9:1 10:1 14:1 18:1 19:1 33:1 160:1 161:1 303:1 304:1 345:1 433:1 434:1 435:1 436:1 437:1 438:1 439:1 440:1 441:1 442:1 443:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (ADVP (RB (However)))(, (,))(NP (NN (mutation))(NN (exon))(CD (3))(NN (beta-catenin))(NN (gene)))(VP (VBD (detected))(SBAR (S (NP (CD (one))(NN (tumour)))(VP (VBD (expressed))(NP (JJ (nuclear))(NN (beta-catenin))(JJ (lining))(JJ (polygonal))(NN (component)))))))) |ET|  |BS| 6:G05.360.340.024.340 8:C04 18:G05.365.590 23:D12.776.091.249 372:G05.360.340.024.340.137.232  |ES| 2:1 6:1 9:1 19:1 34:1 60:1 433:1 862:1 1007:1 1010:1 1011:1 1021:1 1255:1 1256:1 1257:1 1258:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NNS (CONCLUSIONS)))(: (:))(NP (PRP (We)))(VP (VBD (provided))(NP (JJ (first))(NN (evidence))(NN (SOX6))(JJ (novel))(JJ (tumor-suppressor))(NN (gene))(NN (ESCC))(NN (development))(JJ (potential))(JJ (prognostic))(NN (marker))(NN (ESCC))))) |ET|  |BS| 149:G05.360.340.024.340.364.875.890 158:D23.101 206:G05.360.340.024.340.375.249 259:D12.776.395.240.150.500  |ES| 9:1 19:1 35:1 38:1 104:1 239:1 534:1 816:1 827:1 843:1 884:1 891:1 1065:1 1155:1 1156:1 1157:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (ADVP (RB (However)))(, (,))(NP (NP (NP (NN (effect))(NN (HNF4alpha))(NN (cancer))(NN (stem))(NN (cell)))(PRN (-LRB- (-LRB-))(NP (NNS (CSCs)))(-RRB- (-RRB-))))(NP (NP (NN (treatment))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(NN (HNF4alpha)))(VP (VBD (reported)))) |ET|  |BS| 52:E02 104:C04.557.470.200.025.255 332:A11.872.650 556:C11.768.175  |ES| 2:1 10:1 14:1 18:1 19:1 75:1 94:1 123:1 303:1 304:1 433:1 441:1 546:1 993:1 1106:1 1966:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (ADVP (RB (Collectively)))(, (,))(NP (NN (miR-122))(NN (depletion)))(VP (VBZ (facilitates))(NP (NP (NN (cystogenesis))(NN (hepatocarcinogenesis))(NN (mouse))(NN (DEN))(NN (challenge)))(VP (VBG (up-regulating))(NP (NP (JJ (several))(NN (gene)))(VP (VBN (involved))(NP (NP (NN (proliferation)))(, (,))(NP (NN (growth))(NN (factor))(NN (signaling)))(, (,))(NP (NN (neovascularization)))(, (,))(NP (NN (metastasis)))))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 69:G02.111.087.800 113:C04.697.650 150:Z01.542.248.960 344:M01.438 530:C23.550.589.500  |ES| 2:1 9:1 19:1 52:1 102:1 185:1 195:1 262:1 299:1 774:1 806:1 900:1 1371:1 1613:1 1789:1 1872:1 1873:1 1874:1 1875:1 1876:1 1877:1  |EV| 
-5.1698483124001830546490054985043  |BT| (FRAG (SBAR (IN (Although))(S (NP (NN (CTCF)))(VP (VBD (described))(NP (NP (NP (ADJP (RB (significantly))(VBN (mutated)))(NN (gene))(JJ (endometrial))(NN (cancer))(NN (TCGA)))(, (,))(NP (NN (A))(-LRB- (-LRB-))(CD (7))(-RRB- (-RRB-))(NN (track))))(SBAR (S (NP (JJ (variant))(VBG (leading))(NN (T204))(NNS (frameshifts)))(VP (VBD (reported)))))))))) |ET|  |BS| 6:G05.360.340.024.340 86:D01.268.556.435 286:C04.588.945.418.948.585 287:G05.365.590.265  |ES| 2:1 9:1 10:1 14:1 18:1 19:1 69:1 107:1 124:1 229:1 276:1 634:1 639:1 986:1 987:1 988:1 989:1 990:1 991:1 992:1 993:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (ADVP (RB (Here)))(, (,))(NP (VBD (generated))(NN (mouse))(NN (model))(NN (lung))(NN (adenocarcinoma)))(VP (VBN (driven))(NP (NP (NN (mutation))(NN (discoidin))(NN (domain))(NN (receptor))(CD (2))(-LRB- (-LRB-))(NN (DDR2))(-RRB- (-RRB-))(NN (gene)))(JJ (combined))(NN (loss))(NN (TP53))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 66:F01.658.293  |ES| 2:1 9:1 10:1 14:1 19:1 32:1 34:1 52:1 72:1 73:1 148:1 164:1 186:1 255:1 328:1 400:1 920:1 1018:1 1162:1 1173:1 1245:1  |EV| 
-4.1376444685754449892556294798851  |BT| (S (NP (NP (DT (A))(JJ (functional))(JJ (genomic))(NN (approach)))(VP (VBG (integrating))(NP (NP (NN (microarray))(JJ (proteomic))(NN (analysis)))(VP (VBN (done))(NP (NN (laboratory)))))))(VP (VBD (identified))(NP (JJ (14-3-3zeta))(JJ (putative))(NN (oncogene)))(WHNP (WHNP (WP$ (whose))(NN (activation)))(NP (JJ (common))(VBN (driven))(JJ (genomic))(NN (amplification))(NN (lung))(NN (adenocarcinoma)))))) |ET|  |BS| 9:G05.360.340.024.340.375.500 66:F01.658.293 268:H01.158.273.180.350 269:G05.360.340 270:H01.158.201.843 271:N02.278.487  |ES| 19:1 24:1 69:1 225:1 255:1 328:1 415:1 623:1 655:1 661:1 910:1 911:1 912:1 913:1 914:1 915:1 916:1 917:1 918:1 919:1 920:1 921:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (MicroRNA-122)))(VP (VBZ (inhibits))(SBAR (S (NP (JJ (tumorigenic))(NN (property))(JJ (hepatocellular))(NN (carcinoma))(NN (cell)))(VP (VBZ (sensitizes))(NP (NN (cell))(NN (sorafenib)))))))) |ET|  |BS| 41:A11 104:C04.557.470.200.025.255 122:C14.280.383 184:D13.150.650.319 575:V02.050  |ES| 19:1 94:1 303:1 304:1 615:1 841:1 1797:1 1809:1 2062:1 2063:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (MicroRNA))(NNP (301A)))(VP (VBZ (Promotes))(NP (NP (JJ (Intestinal))(NN (Inflammation))(NNP (Colitis-Associated))(NNP (Cancer))(NNP (Development)))(VP (VBG (Inhibiting))(NP (NN (BTG1))))))) |ET|  |BS| 47:A03.556.124 53:C06.405.205.265 122:C14.280.383 184:D13.150.650.319 525:C23.550.470  |ES| 19:1 204:1 1919:1 2054:1 2055:1 2056:1 2057:1 2058:1 2059:1 2060:1 2061:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (miR-490-3p)))(VP (VBD (exhibited))(NP (NP (JJ (progressive))(NN (downregulation))(NN (gastritis)))(, (,))(NP (JJ (intestinal))(NN (metaplasia)))(, (,))(NP (NN (adenocarcinoma))(NN (H)))))) |ET|  |BS| 47:A03.556.124 48:C23.550.589 84:C04.557.470.200.025 85:G02.111.087.225 175:J01.897.280.500.269 179:D01.248.497.300.459.700 180:C06.405.205.697  |ES| 2:1 19:1 109:1 110:1 255:1 595:1 608:1 609:1 610:1 611:1 612:1  |EV| 
-5.1698483124001830546490054985043  |BT| (FRAG (NP (NNS (Results)))(VBP (show))(NP (NN (KLF9))(JJ (haploinsufficient))(NN (suppressor))(NN (colon))(NN (tumorigenesis))(NN (Apc)))(-LRB- (-LRB-))(NP (NP (NP (NP (NN (Min)))(: (/))(CC (+))(-RRB- (-RRB-))(NN (mouse))(NN (part)))(, (,))(NP (NP (NN (repression))(NN (ISG15))(NN (latter))(POS ('s)))(JJ (antiapoptotic))(NN (function)))))) |ET|  |BS| 3:C04.557.470.035.215.100 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 32:C04.697.098.500 33:C04.697.098 38:Z01.058.290.120.180 40:Z01.542.248.700 46:A03.556.124.526.356 207:G05.365.590.029.530.587 208:F01.393.821  |ES| 2:1 10:1 14:1 19:1 33:1 52:1 78:1 113:1 280:1 429:1 451:1 461:1 700:1 702:1 703:1 704:1 705:1 706:1 707:1 708:1 709:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (S (NP (NN (Cdx2)))(VP (VBZ (induces))(NP (NN (differentiation))(JJ (intestinal))(JJ (epithelial))(NN (cell))(NN (vitro)))))(: (;))(S (ADVP (RB (therefore)))(, (,))(VP (VBD (sought))(VP (VB (establish))(SBAR (IN (whether))(S (NP (JJ (causal))(NN (relationship)))(VP (VBZ (exists))(NP (NN (Cdx2))(NN (activation))(JJ (intestinal))(NN (metaplasia)))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 47:A03.556.124 48:C23.550.589 73:N05.715.350.200 74:G04.299.151 75:A11.436  |ES| 2:1 19:1 94:1 109:1 110:1 127:1 213:1 214:1 215:1 216:1 217:1 218:1 219:1 220:1 221:1 222:1 223:1 224:1 225:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NP (NN (Androgen))(JJ (receptor-induced))(NN (tumor))(NN (suppressor)))(, (,))(NP (NN (KLLN)))(, (,)))(VP (VBZ (inhibits))(SBAR (S (NP (NN (breast))(NN (cancer))(NN (growth)))(ADVP (RB (transcriptionally)))(VP (VBZ (activates))(NP (JJ (p53/p73-mediated))(NN (apoptosis))(NN (breast))(NN (carcinoma)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 39:G04.299.139.160 45:G07.700.320.249 122:C14.280.383 206:G05.360.340.024.340.375.249 528:D12.776.826.750.150  |ES| 2:1 7:1 18:1 19:1 23:1 89:1 102:1 301:1 304:1 615:1 700:1 1478:1 1852:1 1853:1 1854:1 1855:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (S (ADVP (RB (Hence)))(, (,))(NP (NN (agent)))(VP (VBD (prevented))(SBAR (S (NP (NN (colon))(NN (cancer)))(VP (VBD (decreased))(NP (NP (JJ (mitotic))(NN (index)))(NP (VBN (altered))(NN (expression))(NN (c-myc)))))))))(, (,))(NP (NN (p16))(NN (p27)))(VP (VBG (suggesting))(NP (NP (NN (modulation))(NN (expression))(NN (gene)))(JJ (potential))(NNS (biomarkers))(JJ (chemopreventive))(NN (activity))))) |ET|  |BS| 155:G05.355.310 158:D23.101 203:G05.360.340.024.340.375.249.375 212:E01.370.225.500.385.500  |ES| 2:1 9:1 18:1 19:1 113:1 115:1 202:1 399:1 455:1 693:1 720:1 721:1 728:1 827:1 1009:1 1124:1 1269:1 1313:1 1943:1 1944:1 1945:1 1946:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Detection))(NN (TFPI2))(NN (methylation))(NN (stool))(NN (DNA)))(VP (MD (may))(VP (VB (act))(NP (JJ (useful))(NN (adjunct))(JJ (noninvasive))(NN (strategy))(NN (screening))(NNS (CRCs))(NN (future)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 36:G02.111.087.029.538 81:E02.095.465.425.400.330.050.400 198:D13.444.308 354:I01.320 355:A12.459  |ES| 19:1 81:1 246:1 491:1 666:1 1036:1 1114:1 1179:1 1184:1 1185:1 1186:1 1187:1 1188:1 1189:1 1190:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (IHH))(NN (SMO)))(VP (MD (may))(SBAR (S (NP (JJ (useful))(NNS (biomarkers))(JJ (diffuse))(NN (cancer)))(VP (MD (may))(VP (VB (show))(NP (NN (growth))(NN (inhibition))(NN (Hh))(NN (antagonist))(NN (cyclopamine))))))))) |ET|  |BS| 43:F01.145.544 45:G07.700.320.249 376:D23.101.140  |ES| 18:1 19:1 102:1 103:1 429:1 491:1 653:1 1036:1 1267:1 1268:1 1269:1 1270:1 1271:1 1272:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NNS (RESULTS))(: (:)))(VP (ADVP (RB (Herein)))(VB (provide))(NP (JJ (new))(NP (NN (evidence))(JJ (transcriptional))(NN (regulation)))(NN (Notch))(NN (PEA3))(NN (breast))(NN (cancer))))) |ET|  |BS| 142:I01.880.604 209:G02.111.087.847  |ES| 18:1 19:1 23:1 38:1 104:1 256:1 428:1 438:1 559:1 710:1 711:1 712:1 713:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NP (CD (One))(JJ (common))(JJ (rate-limiting))(NN (mutation)))(JJ (human))(NN (CRC)))(VP (VBZ (occurs))(NP (JJ (adenomatous))(NN (polyposis))(NN (coli))(-LRB- (-LRB-))(NN (APC))(-RRB- (-RRB-))(NN (gene))))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 21:G05.360.340.024.340.375.249.050 55:B01.050.150.900.649.801.400.112.400.400 194:G05.355.044.250.750  |ES| 9:1 10:1 11:1 14:1 19:1 34:1 36:1 57:1 58:1 59:1 245:1 654:1 655:1 656:1 657:1  |EV| 
5.1698483124001830546490054985043  |BT| (FRAG (PP (JJ (Molecular))(S (VP (VBG (targeting))(NP (NP (NP (NN (GSK3beta))(NN (overexpression))(NN (GSK3beta))(JJ (dominant-negative))(NN (mutant)))(, (,))(NP (JJ (acute-silencing))(NN (GSK3beta))(NN (RNA))(NN (interference)))(, (,)))(VBN (reproduced))(NN (induction)))(NP (ADJP (RB (transcriptionally))(JJ (active)))(NP (NN (p53))(JJ (colorectal))(NN (cancer))(NN (cell)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 38:Z01.058.290.120.180 40:Z01.542.248.700 41:A11 156:G05.355.315.203.374.790  |ES| 2:1 12:1 17:1 18:1 19:1 94:1 152:1 197:1 515:1 516:1 616:1 736:1 811:1 1854:1 1894:1 2114:1 2115:1 2116:1 2117:1  |EV| 
-3.9219848767054372729035094380379  |BT| (S (NP (NN (p53))(NN (activation))(NN (CRC))(NN (cell)))(VP (VBD (interfered))(NP (JJ (IL-6-induced))(NN (invasion))(NN (migration)))(PP (IN (via))(NP (JJ (miR-34a-dependent))(NN (downregulation))(NN (IL6R))(NN (expression)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 41:A11 85:G02.111.087.225 201:D12.644.276.374.465.224  |ES| 12:1 19:1 94:1 115:1 225:1 245:1 514:1 595:1 596:1 620:1 681:1 682:1 683:1 684:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (JJ (Many))(JJ (etiological))(NN (factor)))(, (,))(PP (VBG (including))(NP (NP (NP (NP (NN (hepatitis))(NN (B))(NN (virus))(NN (X))(NN (antigen)))(PRN (-LRB- (-LRB-))(NP (NN (HBx)))(-RRB- (-RRB-))))(NN (p53))(NN (mutation)))(, (,))(NP (VBN (implicated))(NN (hepatocarcinogenesis)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 18:G05.365.590 73:N05.715.350.200  |ES| 2:1 10:1 12:1 14:1 19:1 34:1 185:1 561:1 763:1 900:1 929:1 977:1 1030:1 1422:1 2014:1 2046:1 2047:1 2048:1  |EV| 
-4.812827351939745312847662717104  |BT| (S (ADVP (RB (Moreover)))(, (,))(NP (NN (CDX2))(NN (expression)))(ADVP (RB (progressively)))(VP (VBD (reduced))(NP (JJ (gastric))(NN (dysplasia))(NN (cancer))))) |ET|  |BS| 70:A03.556.875.875  |ES| 2:1 18:1 19:1 86:1 114:1 115:1 201:1 203:1 452:1 622:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Ectopic))(NN (reactivation))(NN (miR-184)))(VP (VBD (inhibited))(SBAR (S (NP (NP (NN (proliferation))(NP (NP (JJ (self-renewal))(JJ (triple))(JJ (negative))(NN (breast))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (TNBC)))(-RRB- (-RRB-))))(NN (cell))(NN (line))(NN (vitro)))(VP (VBN (delayed))(NP (JJ (primary))(NN (tumour))(NN (formation)))))(VP (VBD (reduced))(NP (JJ (metastatic))(NN (burden))(FW (vivo)))))))) |ET|  |BS| 8:C04 20:G03.495 122:C14.280.383 160:C04.588.180.788 543:G04.299.134.220.235  |ES| 10:1 14:1 18:1 19:1 23:1 43:1 94:1 216:1 264:1 299:1 305:1 337:1 344:1 365:1 378:1 449:1 452:1 537:1 1011:1 1716:1 1913:1 1914:1 1915:1 1916:1 1917:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (S (NP (JJS (Most))(JJ (human))(JJ (colorectal))(NN (cancer)))(VP (VB (arise))(NP (NN (accumulation))(NN (series))(JJ (genetic))(NN (alteration))(NN (point))(NN (mutation)))(PP (IN (within))(NP (JJ (Ki-ras))(NN (p53))(NN (gene))))))(, (,))(NP (NN (chemical))(NN (carcinogen)))(VP (MD (may))(VP (VBN (implicated))(NP (NN (event))(ADJP (RB (still))(JJ (unidentified))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 18:G05.365.590 55:B01.050.150.900.649.801.400.112.400.400 279:D27.888.569.100 438:G05.365.590.675  |ES| 2:1 9:1 12:1 17:1 18:1 19:1 34:1 36:1 205:1 491:1 776:1 864:1 951:1 977:1 1807:1 2118:1 2119:1 2120:1 2121:1 2122:1 2123:1 2124:1 2125:1 2126:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (report))))(, (,))(VP (VBP (show))(NP (NP (NP (NP (JJ (synergistic))(NN (action))(NN (HBx))(NN (p53))(NN (mutation))(NN (trigger))(JJ (progressive))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(NN (formation)))(PP (IN (via))(NP (NN (src))(NN (activation))(NN (zebrafish))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 18:G05.365.590 20:G03.495 104:C04.557.470.200.025.255 572:B01.050.150.900.493.200.244.828 573:N05.715.350.200.650  |ES| 2:1 10:1 12:1 14:1 19:1 34:1 43:1 225:1 244:1 303:1 304:1 417:1 429:1 441:1 596:1 610:1 2012:1 2013:1 2014:1 2015:1 2016:1 2017:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (PP (IN (By))(NP (JJ (immunohistochemical))(NN (analysis))))(, (,))(NP (CD (20))(CD (38))(NN (case))(JJ (undifferentiated))(NN (type)))(VP (VBD (advanced))(NP (NP (NN (stomach))(NN (cancer))(NN (K-sam)))(JJ (positive)))(, (,))(PP (IN (whereas))(NP (NP (NN (none))(CD (11))(NN (case)))(SBAR (S (NP (VBN (differentiated))(JJ (intestinal))(NN (type)))(VP (VBD (revealed))(NP (NN (K-sam))(NN (staining)))))))))) |ET|  |BS| 47:A03.556.124 74:G04.299.151 232:D02.886.030.676.180  |ES| 2:1 18:1 19:1 109:1 233:1 275:1 372:1 543:1 661:1 782:1 801:1 803:1 804:1 934:1 997:1 1057:1 1167:1 1605:1 1868:1 1869:1 1870:1 1871:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (ADVP (RB (Moreover)))(, (,))(VP (VBD (identified))(SBAR (S (NP (NN (Usp28))(NN (c-MYC))(NN (target))(NN (gene)))(ADVP (RB (highly)))(VBD (expressed))(NP (JJ (murine))(JJ (human))(JJ (intestinal))(NN (cancer)))(, (,))(VP (VBZ (indicates))(SBAR (S (NP (NN (USP28))(NN (c-MYC))(NN (form))(JJ (positive))(NN (feedback))(NN (loop)))(VP (VBZ (maintains))(NP (JJ (high))(NN (c-MYC))(NN (protein))(NN (level))(NN (tumor))))))))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 55:B01.050.150.900.649.801.400.112.400.400 83:L01.143.283.425 101:C04.588.274.476.411 185:G05.360.340.024.340.375.500.791.420 186:G05.360.340.024.340.375.500.791.420 187:D08.622.705 188:N02.628 189:V02.460  |ES| 2:1 4:1 6:1 7:1 9:1 18:1 19:1 36:1 109:1 160:1 178:1 233:1 247:1 248:1 249:1 622:1 623:1 624:1 625:1 626:1 627:1 628:1 629:1 630:1 631:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (S (NP (DT (This))(JJ (K-Ras))(NN (tumor))(NN (phenotype)))(VP (VBN (associated))(VP (VBD (attenuated))(NP (NN (signaling))(NN (MAPK))(NN (pathway))))))(, (,))(NP (JJ (human))(NN (colon))(NN (cancer))(NN (cell)))(VP (VBG (expressing))(NP (NP (JJ (mutant))(NN (K-Ras))(JJ (hypersensitive))(NN (inhibition))(NN (Raf)))(, (,))(NP (NN (Mek)))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 8:C04 41:A11 43:F01.145.544 55:B01.050.150.900.649.801.400.112.400.400 69:G02.111.087.800 80:G05.695 233:D08.811.913.696.620.682.700.565 234:D08.811.913.696.620.682.700.565  |ES| 2:1 7:1 13:1 18:1 19:1 36:1 94:1 103:1 113:1 169:1 195:1 236:1 383:1 807:1 808:1 809:1 810:1 811:1 812:1 813:1 814:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (miRNA-548p)))(VP (VBZ (suppresses))(NP (NP (NN (hepatitis))(NN (B))(NN (virus))(NN (X))(NN (protein)))(VP (VBN (associated))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(VP (VBG (downregulating))(NP (NN (oncoprotein))(NN (hepatitis))(NN (B))(JJ (x-interacting))(NN (protein))))))))) |ET|  |BS| 104:C04.557.470.200.025.255 184:D13.150.650.319 584:D12.776.624.664  |ES| 4:1 19:1 169:1 303:1 304:1 686:1 763:1 929:1 1422:1 2048:1 2065:1 2111:1 2112:1 2113:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NP (NNS (Mice)))(VP (VBG (lacking))(NP (NN (MAT1A)))))(VP (VBD (reduced))(NP (JJ (hepatic))(NN (S-adenosylmethionine))(NN (content))(NN (hyperplasia)))(ADVP (RB (spontaneously)))(VP (VB (develop))(NP (JJ (nonalcoholic))(NN (steatohepatitis)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 232:D02.886.030.676.180 509:C06.552.241.519 510:C23.550.444  |ES| 19:1 376:1 452:1 583:1 648:1 838:1 1506:1 1791:1 1792:1 1793:1 1794:1 1795:1 1796:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NP (NN (miRNA-141)))(, (,))(VP (VBD (downregulated))(NP (JJ (pancreatic))(NN (cancer))))(, (,)))(VP (VBZ (inhibits))(NP (NN (cell))(NN (proliferation))(NN (invasion)))(S (VP (ADVP (RB (directly)))(VBG (targeting))(NP (NN (MAP4K4))))))) |ET|  |BS| 122:C14.280.383 183:G04.299.233.750 184:D13.150.650.319  |ES| 2:1 18:1 19:1 94:1 299:1 426:1 465:1 467:1 615:1 616:1 619:1 620:1 621:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (PURPOSE))(: (:)))(NN (IFITM3))(, (,))(JJ (IFN-inducible))(NN (gene)))(, (,))(NP (VBN (overexpressed))(JJ (human))(JJ (colorectal))(NN (cancer)))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 55:B01.050.150.900.649.801.400.112.400.400  |ES| 2:1 9:1 17:1 18:1 19:1 25:1 36:1 104:1 687:1 696:1 697:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (DEP))(NN (domain)))(VP (VP (VBG (containing))(NP (CD (1))(-LRB- (-LRB-))(NN (DEPDC1))(-RRB- (-RRB-))))(SBAR (S (NP (ADJP (RB (newly))(VBN (identified)))(NP (JJ (cancer-related))(NN (cell))(NN (cycle)))(JJ (related))(NN (gene)))(VP (VBD (demonstrated))(NP (JJ (novel))(JJ (therapeutic))(NN (target))(NN (bladder))(NN (cancer)))))))) |ET|  |BS| 6:G05.360.340.024.340 52:E02 259:D12.776.395.240.150.500 353:G04.299.134  |ES| 9:1 10:1 14:1 18:1 19:1 94:1 98:1 160:1 286:1 419:1 541:1 564:1 601:1 623:1 891:1 1143:1 1144:1 1172:1 1173:1 1174:1 1175:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (ADJP (RB (Here))(VBN (investigated)))(NN (prevalence))(NN (pattern))(NN (mutation)))(NP (NP (CD (two))(NN (gene)))(, (,))(NP (NN (Ha-ras))(NN (beta-catenin)))(, (,)))(VP (VBN (known))(NP (JJ (mutational))(NN (target))(NN (mouse))(NN (hepatocarcinogenesis))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 23:D12.776.091.249 60:E05.318.308.985.525.750 216:Z01.107.084.900.425  |ES| 2:1 9:1 19:1 34:1 52:1 60:1 160:1 179:1 260:1 400:1 403:1 556:1 747:1 900:1 933:1 1244:1  |EV| 
-2.6513060191238082552445121109486  |BT| (S (S (VP (VBG (Crossing))(NP (NP (NP (NN (Apc)))(PRN (-LRB- (-LRB-))(NP (NN (Delta14)))(: (/))(CC (+))(-RRB- (-RRB-))))(NP (NP (NN (mouse))(JJ (prone))(JJ (spontaneous))(JJ (intestinal))(NN (tumor))(NN (development))(NN (pCdx2-9LacZ)))(NP (JJ (transgenic))(NN (mouse))(S (VP (VBG (containing))(NP (NN (LacZ))(NN (reporter))(NN (control))(JJ (9.3-kb))(NN (Cdx2))(NN (promoter))))))))))(VP (VBD (showed))(SBAR (S (NP (NN (promoter))(NN (segment)))(VP (VBZ (contains))(NP (NP (NN (sequence)))(VP (VBG (recapitulating))(NP (NN (decrease))(NN (Cdx2))(NN (expression))(JJ (intestinal))(NN (cancer)))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 11:B01.050.150.900.649.865.635.505.500 26:G02.111.570.080 99:B01.050.050.136.500 100:G05.360.340.024.686.545 101:C04.588.274.476.411 102:C04.588.274.476.411 103:G11.427.695.525  |ES| 7:1 10:1 14:1 18:1 19:1 35:1 52:1 83:1 109:1 115:1 132:1 213:1 279:1 280:1 281:1 282:1 283:1 284:1 285:1 286:1 287:1 288:1 289:1 290:1 291:1 292:1 293:1 294:1 295:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (ADVP (RB (Interestingly)))(, (,))(NP (NP (NP (JJ (gastric))(NN (adenocarcinoma)))(ADJP (RB (significantly))(JJ (frequent)))(NN (Pdx-1-Cre)))(: (;))(NP (NN (Smad4))(-LRB- (-LRB-))(NN (F/F))(-RRB- (-RRB-)))(: (;))(NP (NN (Trp53))(-LRB- (-LRB-))(NN (F/F))(-RRB- (-RRB-)))(: (;))(NP (NP (NP (NN (Cdh1))(-LRB- (-LRB-))(NN (F))(-RRB- (-RRB-)))(PRN (-LRB- (-LRB-))(: (/))(CC (+))(-RRB- (-RRB-))))(NN (mouse))(NN (Pdx-1-Cre)))(: (;))(NP (NN (Smad4))(-LRB- (-LRB-))(NN (F/F))(-RRB- (-RRB-)))(: (;))(NP (NN (Trp53))(-LRB- (-LRB-))(NN (F/F))(-RRB- (-RRB-)))(: (;))(NP (NN (Cdh1))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(CC (+))(-RRB- (-RRB-)))(NN (mouse)))(, (,))(S (NP (VBG (demonstrating))(NN (Cdh1))(NN (heterozygosity)))(VP (VBZ (accelerates))(NP (NN (development))(NN (progression))(JJ (gastric))(NN (adenocarcinoma)))))(, (,))(NP (NN (combination))(NN (loss))(NN (Smad4))(NN (p53)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 11:B01.050.150.900.649.865.635.505.500 16:C23.550.291.656 70:A03.556.875.875 84:C04.557.470.200.025 118:D01.248.497.158.380 157:G05.380.383  |ES| 2:1 10:1 12:1 14:1 19:1 32:1 35:1 48:1 51:1 52:1 86:1 124:1 217:1 255:1 518:1 519:1 520:1 521:1 522:1 523:1 524:1 525:1 526:1 527:1 528:1 529:1 530:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NP (PRP$ (Our))(VBN (integrated))(NN (microRNA)))(VP (VBG (profiling))(NP (NN (approach)))))(VP (VBD (identified))(S (NP (NN (miR-195-5p)))(ADVP (RB (independently)))(VP (VBN (associated))(NP (NN (prognosis))(NN (CRC))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 163:E01.789 184:D13.150.650.319  |ES| 19:1 169:1 245:1 271:1 544:1 623:1 658:1 857:1 911:1 2147:1 2148:1 2149:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (Loss))(NN (miR-122))(NN (cause))(JJ (chronic))(NN (steatohepatitis)))(NP (JJ (spontaneous))(JJ (hepatocellular))(NN (carcinoma))))) |ET|  |BS| 73:N05.715.350.200 104:C04.557.470.200.025.255 508:C06.552.241  |ES| 19:1 283:1 303:1 304:1 1779:1 1788:1 1789:1 1790:1 1791:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Hepatic))(NN (loss))(NN (miR-122)))(VP (VBZ (predisposes))(NP (NN (mouse))(JJ (hepatobiliary))(NN (cyst))(JJ (hepatocellular))(NN (carcinoma)))(PP (IN (upon))(NP (NN (diethylnitrosamine))(NN (exposure)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 104:C04.557.470.200.025.255 554:D02.654.442.200 555:C04.182  |ES| 19:1 32:1 52:1 303:1 304:1 1789:1 1947:1 1948:1 1949:1 1950:1 1951:1 1952:1 1953:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (PRP (We)))(VP (VBD (examined))(NP (JJ (biological))(NN (function))(NP (NP (JJ (related))(JJ (molecular))(NN (mechanism))(NN (PAX5))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))))) |ET|  |BS| 104:C04.557.470.200.025.255 141:G16.100 243:D12.776.260.645.500  |ES| 10:1 14:1 19:1 33:1 161:1 162:1 303:1 304:1 324:1 419:1 440:1 441:1 843:1 846:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (PP (IN (As))(NP (NN (result))))(, (,))(NP (NP (NN (CDCA1))(JJ (novel))(NN (cancer-testis))(NN (antigen))(JJ (overexpressed))(NN (LC)))(, (,))(NP (JJ (cholangiocellular))(NN (cancer)))(, (,))(NP (JJ (urinary))(NN (bladder))(NN (cancer))(JJ (renal))(NN (cell))(NN (cancer)))(, (,))(NP (NN (CDCA1)))(VP (MD (may))(ADVP (RB (therefore)))(NP (JJ (ideal))(NN (TAA))(JJ (useful))(NN (diagnosis))(NN (immunotherapy))(NN (cancer))))))) |ET|  |BS| 259:D12.776.395.240.150.500 263:E01 295:C04.557.470.200.025.390 296:D02.065.064.786 297:C14.907.055.239.125 298:E02.095.465.425 299:D23.050  |ES| 2:1 18:1 19:1 25:1 94:1 101:1 168:1 218:1 491:1 564:1 891:1 922:1 1028:1 1029:1 1030:1 1031:1 1032:1 1033:1 1034:1 1035:1 1036:1 1037:1 1038:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (K-ras))(NN (mutation)))(VP (VBP (occur))(ADVP (RB (frequently)))(S (NP (NN (colon))(NN (cancer)))(VP (VBP (contribute))(NP (JJ (autonomous))(NN (growth))))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 18:G05.365.590 45:G07.700.320.249  |ES| 18:1 19:1 34:1 102:1 113:1 450:1 698:1 1121:1 2044:1 2045:1  |EV| 
-5.1698483026214034907752647995949  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (NN (Expression))(NN (ra))(NN (protein))(NN (type))(CD (II))(JJ (alveolar))(NNS (pneumocytes))(NN (mutation))(NN (codon))(CD (12))(JJ (K-ras))(NN (gene))(NN (lung))(NN (tissue)))(VP (MD (may))(VP (VB (contribute))(NP (NN (induction))(NN (lung))(NN (carcinoma))(NN (patient))(NN (IPF))))))) |ET|  |BS| 18:G05.365.590 50:M01.643 98:A10 182:A04.411 265:C04.557.470.200 276:C08.381.483.487.500 334:D08.811.277.040.330.300.400.500 335:D13.444.735.544.355 336:A04.411.715.512 337:C08.381.765  |ES| 4:1 9:1 19:1 34:1 104:1 120:1 239:1 272:1 304:1 316:1 328:1 450:1 491:1 543:1 736:1 1115:1 1116:1 1117:1 1118:1 1119:1 1120:1 1121:1 1122:1  |EV| 
5.1698483124001830546490054985043  |BT| (FRAG (SBAR (IN (Although))(NP (NP (NP (VBN (induced))(NN (cell))(NN (death)))(VBN (regarded))(JJ (major))(NN (component))(NN (p53))(JJ (tumor-suppressive))(NN (activity)))(, (,))(S (ADVP (RB (recently)))(VP (VBD (found))(SBAR (S (NP (JJ (sustained))(NN (p53))(NN (activation))(JJ (subsequent))(NN (DNA))(NN (damage)))(VP (VBZ (promotes))(NP (JJ (inflammation-associated))(NN (hepatocarcinogenesis))))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 8:C04 134:G04.299.139 525:C23.550.470 526:G05.355.180  |ES| 2:1 12:1 19:1 37:1 94:1 107:1 177:1 225:1 298:1 399:1 411:1 412:1 462:1 666:1 772:1 900:1 1021:1 1319:1 1521:1 1847:1 1848:1 1849:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (Amplification))(NN (HER2)))(PRN (-LRB- (-LRB-))(NP (NP (NN (ErbB2)))(, (,))(NP (NN (c-Neu))))(-RRB- (-RRB-))))(NP (NP (NN (proto-oncogene))(NN (breast))(NN (cancer)))(NP (VBN (associated))(JJ (poor))(NN (prognosis))(JJ (high))(NN (relapse))(NN (rate))))) |ET|  |BS| 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 159:I01.880.735.634 163:E01.789 235:G05.360.340.024.340.375.500.791 527:C23.550.291.937  |ES| 2:1 10:1 14:1 18:1 19:1 23:1 41:1 169:1 178:1 188:1 544:1 545:1 563:1 1012:1 1705:1 1850:1 1851:1  |EV| 
-4.0303666629074541560839861631393  |BT| (S (NP (NN (Evaluation))(NN (RB))(NN (status)))(VP (MD (may))(NP (JJ (useful))(JJ (prognostic))(NN (factor))(JJ (human))(NN (HCC))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 225:E05.337  |ES| 19:1 36:1 185:1 416:1 441:1 491:1 884:1 1036:1 1208:1 1209:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (MicroRNA-221)))(VP (VBZ (governs))(S (NP (NN (tumor))(NN (suppressor))(NN (HDAC6)))(VP (VB (potentiate))(NP (JJ (malignant))(NN (progression))(NN (liver))(NN (cancer))))))) |ET|  |BS| 16:C23.550.291.656 30:Z01.058.290.190.800 31:D08.811.520.224.800 184:D13.150.650.319 206:G05.360.340.024.340.375.249 231:C04.557.465.625.600.380.590  |ES| 7:1 18:1 19:1 48:1 700:1 802:1 836:1 2072:1 2073:1 2074:1 2075:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (S (NP (NN (Mouse))(NN (strain)))(VP (VBD (disrupted))(S (NP (NP (NN (sPLA)))(-LRB- (-LRB-))(CD (2))(-RRB- (-RRB-))(NN (gene))(JJ (susceptible))(NN (Min))(NN (phenotype)))(VP (VBP (develop))(NP (JJ (numerous))(JJ (intestinal))(NN (polyp))))))(, (,)))(IN (whereas))(S (NP (NP (NN (mouse))(JJ (normal))(NN (sPLA)))(PRN (-LRB- (-LRB-))(NP (CD (2)))(-RRB- (-RRB-))))(VP (VBP (develop))(NP (JJ (limited))(NN (number))(NN (polyp)))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 80:G05.695 192:D08.811.277.352.100.680.750.937.750 193:C23.300.825.411 444:C23.300.825  |ES| 2:1 9:1 10:1 14:1 19:1 52:1 109:1 118:1 148:1 236:1 372:1 646:1 647:1 648:1 650:1 899:1 2039:1 2127:1 2128:1 2129:1 2130:1 2131:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (DT (The))(NN (ECM-modulator))(NN (inter)))(: (-))(S (NP (NP (NN (alpha-trypsin))(NN (inhibitor))(JJ (heavy))(NN (chain))(NN (family))(NN (member)))(CD (five))(-LRB- (-LRB-))(NN (ITIH5))(-RRB- (-RRB-)))(ADVP (RB (recently)))(VP (VBD (identified))(NP (NP (NN (tumor))(NN (suppressor)))(VP (ADVP (RB (potentially)))(VP (VBN (involved))(NP (NP (VBG (impairing))(NN (breast))(NN (cancer))(NN (progression))(JJ (molecular))(NN (mechanism)))(VP (VBG (underlying))(S (NP (NN (function)))(ADJP (ADVP (RB (still)))(JJ (elusive)))))))))))) |ET|  |BS| 16:C23.550.291.656 44:F01.829.263 206:G05.360.340.024.340.375.249 223:A11.284.295.310  |ES| 7:1 10:1 14:1 18:1 19:1 23:1 33:1 48:1 97:1 161:1 162:1 380:1 435:1 623:1 691:1 700:1 764:1 765:1 766:1 767:1 768:1 769:1 770:1 771:1 772:1 773:1 774:1 775:1 776:1 777:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (ADVP (RB (Instead)))(, (,))(NP (NNS (data)))(VP (VBD (revealed))(NP (NP (NP (NN (Skp2)))(VBN (regulated))(NN (Myc))(NN (activity)))(, (,))(NP (JJ (oncogenic))(JJ (potential))(NN (generation))(JJ (hepatocellular))(NN (carcinoma)))))) |ET|  |BS| 104:C04.557.470.200.025.255 142:I01.880.604 279:D27.888.569.100 506:F01.829.263.315 507:D12.776.157.743  |ES| 2:1 19:1 275:1 303:1 304:1 399:1 793:1 827:1 953:1 1664:1 1784:1 1785:1 1786:1 1787:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Amplification))(NN (over-expression))(NN (MAP3K3))(NN (gene))(JJ (human))(NN (breast))(NN (cancer)))(VP (VBZ (promotes))(NP (NN (formation))(NN (survival))(NN (breast))(NN (cancer))(NN (cell))))) |ET|  |BS| 20:G03.495 55:B01.050.150.900.649.801.400.112.400.400 108:G04.299.316 155:G05.355.310  |ES| 9:1 18:1 19:1 23:1 36:1 43:1 94:1 274:1 298:1 1012:1 1013:1 1014:1  |EV| 
-4.0848657255017997158574871718884  |BT| (FRAG (ADVP (RB (Furthermore)))(, (,))(NP (NP (JJ (high))(NN (uniform))(NN (expression))(NN (CDX2)))(NP (NP (JJ (characteristic))(JJ (metastatic))(JJ (colorectal))(NN (cancer)))(, (,))(NP (ADJP (ADJP (JJ (weak)))(CC (and/or))(ADJP (JJ (focal))))(NN (CDX2))(NN (expression))(JJ (alert))(JJ (surgical))(NN (pathologist))(NN (possibility))(JJ (primary))(NN (lung))(NN (adenocarcinoma)))(, (,))(NP (ADVP (RB (especially)))(NN (presence))(NN (goblet))(NN (cell))(NN (morphology)))))) |ET|  |BS| 113:C04.697.650 114:J01.637.215 115:E04  |ES| 2:1 17:1 18:1 19:1 94:1 114:1 115:1 149:1 178:1 255:1 328:1 334:1 335:1 336:1 337:1 338:1 339:1 340:1 341:1 342:1 343:1 344:1 345:1 346:1 347:1 348:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Heterozygous))(NN (disruption))(NN (PTEN)))(VP (VBZ (promotes))(NP (NP (JJ (intestinal))(NN (neoplasia))(NN (APCmin)))(: (/))(NP (CC (+))(NP (NN (mouse)))(: (:))(NP (NN (role))))(NP (NN (osteopontin)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 15:F01.829.316.616 102:C04.588.274.476.411 157:G05.380.383 350:D12.644.276.374.625  |ES| 19:1 31:1 52:1 104:1 109:1 298:1 640:1 1160:1 1602:1 1936:1 1962:1 1963:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (S (NP (JJ (Ectopic))(NN (expression))(NN (miR-155)))(VP (VBD (promoted))(NP (NP (NP (NN (growth))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(NN (cell)))))(, (,))(IN (whereas))(S (NP (NN (depletion)))(VP (VBD (inhibited))(NP (NN (cell))(NN (growth)))))) |ET|  |BS| 41:A11 45:G07.700.320.249 104:C04.557.470.200.025.255 107:G05.355.315.202 122:C14.280.383  |ES| 2:1 10:1 14:1 19:1 94:1 102:1 115:1 303:1 304:1 305:1 365:1 372:1 441:1 1613:1 1911:1 1912:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (JJ (Intestinal))(NN (metaplasia))(NN (dysplasia))(JJ (low))(NN (expression))(NN (CDX2)))(VP (MD (may))(VP (VB (serve))(NP (JJ (predictive))(NN (marker))(JJ (gastric))(NN (cancer)))))) |ET|  |BS| 47:A03.556.124 48:C23.550.589 158:D23.101  |ES| 18:1 19:1 86:1 110:1 114:1 115:1 203:1 204:1 491:1 531:1 532:1 533:1 534:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (study))))(, (,))(VP (VBP (demonstrate))(S (NP (NP (NP (NN (histone))(NN (deacetylase))(NN (inhibitor)))(PRN (-LRB- (-LRB-))(NP (NN (HDACi)))(-RRB- (-RRB-))))(NN (vorinostat))(NN (LBH589)))(VP (ADVP (RB (significantly)))(VBP (downregulate))(NP (NN (TS))(NN (gene))(NN (expression))(NN (panel))(NN (colon))(NN (cancer))(NN (cell))(NN (line))))))) |ET|  |BS| 94:A11.251.210 153:D27.505.519.389.360 154:Z01.058.266.887 155:G05.355.310  |ES| 2:1 9:1 10:1 14:1 18:1 19:1 94:1 113:1 115:1 124:1 131:1 244:1 264:1 380:1 502:1 503:1 504:1 505:1 506:1 507:1 508:1 509:1 510:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (PRP (We)))(VP (VBD (aimed))(VP (VB (investigate))(SBAR (IN (whether))(S (NP (NN (Notch1))(NN (signaling)))(VP (VBZ (contributes))(NP (NN (carcinogenesis))(JJ (gastric))(NN (cancer))(NN (CD133))(NN (induction))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 33:C04.697.098 69:G02.111.087.800  |ES| 18:1 19:1 86:1 195:1 207:1 221:1 459:1 651:1 652:1 736:1 843:1 844:1 845:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (Astrocyte))(JJ (elevated))(NN (gene-1))(NN (c-Myc)))(VP (VBP (cooperate))(VP (VBP (promote))(NP (NN (hepatocarcinogenesis))(NN (mouse)))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 529:A08.637.200  |ES| 19:1 52:1 474:1 679:1 756:1 824:1 900:1 1858:1 1859:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (MicroRNA-608)))(VP (VBZ (inhibits))(NP (NN (proliferation))(NN (bladder))(NN (cancer)))(PP (IN (via))(NP (NP (NN (AKT/FOXO3a)))(NN (signaling))(NN (pathway)))))) |ET|  |BS| 69:G02.111.087.800 122:C14.280.383 126:G02.111.087.800 184:D13.150.650.319 378:D08.811.913.696.620.682.700.755  |ES| 18:1 19:1 195:1 299:1 383:1 564:1 596:1 615:1 2077:1 2078:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (S (NP (NP (NNS (Mice)))(VP (VBG (lacking))(NP (NP (NN (methionine))(NN (adenosyltransferase))(NN (1A)))(PRN (-LRB- (-LRB-))(NP (NN (MAT1A)))(-RRB- (-RRB-))))))(VP (VBD (reduced))(NP (NN (PHB1))(NN (expression)))))(, (,))(JJ (impaired))(JJ (mitochondrial))(NN (function)))(, (,))(VP (ADVP (RB (spontaneously)))(VB (develop))(NP (NP (JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 104:C04.557.470.200.025.255 565:A11.284.430.214.190.875.564 567:G05.360.340.024.340.365 574:D08.811.913.225.650  |ES| 2:1 10:1 14:1 19:1 33:1 115:1 303:1 304:1 376:1 441:1 452:1 583:1 648:1 1506:1 1792:1 2003:1 2004:1 2050:1 2051:1 2052:1 2053:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Antagonism))(NN (miR-221))(NN (miR-222)))(VP (VBZ (reduces))(NP (NN (growth))(NN (colon))(NN (tumor))(NN (mouse))(NN (colitis))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 45:G07.700.320.249 51:C04.588.274.476.411.307.180 53:C06.405.205.265  |ES| 7:1 19:1 52:1 102:1 113:1 139:1 140:1 141:1 142:1 143:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NNS (data)))(VP (VBP (indicate))(SBAR (S (NP (NN (LHX4)))(VP (MD (may))(VP (VB (act))(NP (JJ (potential))(NN (tumor))(NN (suppressor))(NN (hepatocarcinogenesis)))(, (,))(S (VP (VBG (suggesting))(S (VP (VBG (targeting))(NP (NN (LHX4))))))))))))(VP (VBP (downregulate))(SBAR (S (NP (NN (AFP)))(VP (MD (might))(NP (JJ (therapeutic))(NN (implication)))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 81:E02.095.465.425.400.330.050.400 206:G05.360.340.024.340.375.249  |ES| 2:1 7:1 19:1 85:1 244:1 246:1 491:1 508:1 541:1 616:1 700:1 793:1 798:1 827:1 900:1 1009:1 1196:1 1284:1 1479:1 1982:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NNS (METHODS))(: (:)))(S (NP (NN (Notch))(NN (status)))(VP (VBD (analysed))(S (VP (VBG (studying))(S (NP (NN (expression))(NN (Notch))(NN (effector))(NN (Hes1))(NN (Notch))(NNS (ligands/receptors)))(NP (JJ (human))(JJ (colorectal))(NP (NP (NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (CRC)))(-RRB- (-RRB-))))(NN (mouse))(NN (model))(NN (Apc))(NN (mutation))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 55:B01.050.150.900.649.801.400.112.400.400 168:E05.581 169:D12.776.543.750.725 170:D27.720.470.480  |ES| 10:1 14:1 17:1 18:1 19:1 34:1 36:1 52:1 72:1 104:1 115:1 245:1 256:1 258:1 280:1 416:1 565:1 568:1 569:1 570:1 571:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NP (NP (NN (MicroRNA-122)))(PRN (-LRB- (-LRB-))(NP (NN (miR-122)))(-RRB- (-RRB-))))(, (,))(NP (ADJP (RB (highly))(JJ (abundant)))(JJ (liver-specific))(NN (miRNA)))(, (,)))(VP (VBP (act))(NP (NP (NN (tumor))(NN (suppressor))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))) |ET|  |BS| 81:E02.095.465.425.400.330.050.400 104:C04.557.470.200.025.255 184:D13.150.650.319 206:G05.360.340.024.340.375.249 242:A03.620  |ES| 2:1 7:1 10:1 14:1 19:1 246:1 303:1 304:1 441:1 626:1 700:1 840:1 1789:1 1797:1 1798:1 1799:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NN (AIM))(: (:)))(S (VP (TO (To))(VP (VB (examine))(NP (NN (status))(NP (NP (JJ (clinical))(NN (significance))(JJ (anaplastic))(NN (lymphoma))(NN (kinase)))(PRN (-LRB- (-LRB-))(NP (NN (ALK)))(-RRB- (-RRB-))))(NN (gene))(NP (NP (NN (alteration))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(NN (patient))))))) |ET|  |BS| 6:G05.360.340.024.340 30:Z01.058.290.190.800 31:D08.811.520.224.800 50:M01.643 104:C04.557.470.200.025.255  |ES| 9:1 10:1 14:1 19:1 84:1 104:1 120:1 303:1 304:1 416:1 441:1 470:1 557:1 591:1 828:1 951:1 959:1 960:1 961:1 962:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (MiR-122)))(VP (VBZ (inhibits))(NP (NP (NN (cell))(NN (proliferation))(NN (tumorigenesis))(NN (breast))(NN (cancer)))(VP (VBG (targeting))(NP (NN (IGF1R))))))) |ET|  |BS| 32:C04.697.098.500 33:C04.697.098 122:C14.280.383 183:G04.299.233.750  |ES| 18:1 19:1 23:1 78:1 94:1 299:1 615:1 616:1 2090:1 2091:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Downregulation))(NN (miR-610)))(VP (VBZ (promotes))(SBAR (S (NP (NN (proliferation))(NN (tumorigenicity)))(VP (VBZ (activates))(NP (NN (Wnt/beta-catenin))(NN (signaling))(JJ (human))(JJ (hepatocellular))(NN (carcinoma)))))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 85:G02.111.087.225 104:C04.557.470.200.025.255 105:G02.149.115.800.925  |ES| 19:1 36:1 195:1 296:1 297:1 298:1 299:1 300:1 301:1 302:1 303:1 304:1  |EV| 
-5.1698483124001830546490054985043  |BT| (FRAG (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NP (VBN (defined))(NN (subset))(NN (bone))(JJ (soft))(NN (tissue))(NN (tumor)))(, (,))(PP (VBG (including))(NP (JJ (benign))(NN (tumor))))(, (,))(S (NP (NN (Akt)))(ADVP (RB (frequently)))(VP (VBN (overexpressed))(S (VP (VBN (activated))))))(, (,))(NP (NP (NNP (AKT1/2))(NN (copy))(NN (number)))(VP (VBN (increased)))))) |ET|  |BS| 378:D08.811.913.696.620.682.700.755 379:C04.588.839 380:A02.835.232 381:C04  |ES| 2:1 7:1 19:1 25:1 47:1 163:1 244:1 272:1 561:1 646:1 680:1 698:1 963:1 1284:1 1285:1 1286:1 1287:1 1288:1 1289:1 1290:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (ITF-2)))(VP (VP (VBD (disrupted))(PP (IN (via))(NP (JJ (allelic))(NN (loss))(NN (chromosome))(NN (18q21)))))(, (,))(SBAR (S (NP (NN (ITF-2B))(NN (expression)))(VP (VBD (lost))(NP (JJ (adenoma-carcinoma))(NN (transition)))))))) |ET|  |BS| 17:C04.557.470.035 289:A11.284.187 290:G05.365.590.029.530 317:C04.557.470.200.430  |ES| 2:1 19:1 32:1 115:1 552:1 596:1 1005:1 1475:1 2038:1 2039:1 2040:1 2041:1 2042:1 2043:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (CONCLUSION))(: (:)))(NP (DT (These))(JJ (clinical))(JJ (mechanistic))(NN (finding)))(VP (VBP (indicate))(SBAR (S (NP (NP (NN (IFITM3))(JJ (direct))(JJ (transcriptional))(NN (target))(NN (KLF4)))(VBN (dysregulated))(NP (NN (KLF4)))(NN (expression)))(VP (VBP (lead))(NP (JJ (aberrant))(NN (IFITM3))(NN (expression)))(, (,))(S (ADVP (RB (thus)))(VP (VBG (contributing))(NP (NN (colon))(NN (cancer))(NN (progression))(NN (metastasis)))))))))) |ET|  |BS| 16:C23.550.291.656 86:D01.268.556.435 113:C04.697.650 209:G02.111.087.847  |ES| 2:1 18:1 19:1 48:1 84:1 104:1 113:1 115:1 160:1 254:1 559:1 696:1 792:1 806:1 927:1 1259:1 1295:1 1334:1 1479:1 1725:1 1882:1 1890:1 1891:1 1892:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (JJ (Sonic))(NN (hedgehog))(NN (inhibitor)))(VP (VBP (prevent))(NP (JJ (colitis-associated))(NN (cancer)))(FRAG (IN (via))(NP (VBN (orchestrated))(NN (mechanism))(NN (IL-6)))(: (/))(NP (NP (NN (gp130))(NN (inhibition)))(, (,))(NP (NN (15-PGDH))(NN (induction)))(, (,))(NP (NN (Bcl-2))(NN (abrogation)))(, (,))(NP (NN (tumorsphere))(NN (inhibition))))))) |ET|  |BS| 43:F01.145.544 53:C06.405.205.265 54:G05.360.340.024.340.375.500.791.150 201:D12.644.276.374.465.224 214:B01.050.150.900.649.473.376  |ES| 2:1 18:1 19:1 103:1 133:1 158:1 162:1 380:1 410:1 596:1 731:1 732:1 733:1 734:1 735:1 736:1 737:1 738:1  |EV| 
-3.3546253045031448891677428036928  |BT| (S (NP (NN (miR-137)))(VP (VBZ (regulates))(SBAR (S (NP (JJ (constitutive))(NN (androstane))(NN (receptor)))(VP (VBZ (modulates))(NP (NN (doxorubicin))(NN (sensitivity))(JJ (parental))(JJ (doxorubicin-resistant))(NN (neuroblastoma))(NN (cell)))))))) |ET|  |BS| 41:A11 136:D02.455.426.559.847.562.050.200.175 137:C04.557.465.625.600.590.650.550 138:F01.829.263.500.320  |ES| 19:1 94:1 186:1 420:1 422:1 423:1 424:1 599:1 603:1 604:1 605:1 606:1 607:1  |EV| 
5.1698483124001830546490054985043  |BT| (FRAG (PP (IN (In))(NP (NP (NP (NN (azoxymethane)))(PRN (-LRB- (-LRB-))(NP (NN (AOM)))(-RRB- (-RRB-))))(NN (model))(NN (colon))(NN (cancer))))(, (,))(NP (NP (NN (addition))(NN (K-ras))(NN (mutation)))(, (,))(VP (VBN (shown))(S (NP (ADJP (ADJP (JJ (wild-type)))(PRN (-LRB- (-LRB-))(ADJP (JJ (WT)))(-RRB- (-RRB-))))(NN (Ras)))(VP (VBD (activated))(NP (NP (JJ (upstream))(NN (pathway)))(, (,))(S (VBG (including))(, (,))(PP (FW (e.g.)))(, (,))(VP (VBG (signaling))(NP (NN (ErbB))(NN (receptor))))))))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 18:G05.365.590 69:G02.111.087.800 132:D02.172.080 563:D08.811.913.696.620.682.725.400.009  |ES| 2:1 8:1 10:1 14:1 18:1 19:1 34:1 72:1 113:1 163:1 186:1 195:1 237:1 244:1 383:1 468:1 561:1 1121:1 1775:1 1993:1 1994:1 1995:1 1996:1 1997:1 1998:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (JJ (Oncogenic))(NN (mutation))(NN (K-ras))(NN (gene)))(VP (VBP (occur))(NP (NP (QP (RB (approximately))(CD (50)))(NN (%)))(NP (JJ (human))(JJ (colorectal))(NN (cancer)))))) |ET|  |BS| 4:C04.588.274.476.411.307 18:G05.365.590 55:B01.050.150.900.649.801.400.112.400.400 279:D27.888.569.100  |ES| 9:1 17:1 18:1 19:1 34:1 36:1 368:1 369:1 1121:1 1843:1 2044:1 2143:1  |EV| 
-0.40862310089882214469980681315064  |BT| (S (NP (NP (NN (Detection)))(VP (VBN (methylated))(NP (NN (TBX5)))))(VP (MD (may))(VP (VB (serve))(NP (JJ (potential))(NN (biomarker))(NN (prognosis))(NN (malignancy)))))) |ET|  |BS| 36:G02.111.087.029.538 158:D23.101 163:E01.789  |ES| 19:1 49:1 491:1 532:1 544:1 827:1 885:1 1179:1 1180:1 1183:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NN (overexpression))(NN (PPARgamma1))(NN (gene)))(VP (VBZ (exerts))(NP (NP (JJ (beneficial))(NN (effect)))(VP (VBG (attenuating))(NP (NN (atherosclerosis))(NN (progression))))))(VP (VBZ (stabilizes))(NP (JJ (vulnerable))(NN (plaque))))) |ET|  |BS| 6:G05.360.340.024.340 16:C23.550.291.656 511:C14.907.137.126.307 513:C14.907.137.126 558:C23.300.821  |ES| 2:1 9:1 19:1 48:1 75:1 152:1 244:1 984:1 1284:1 1803:1 1804:1 1977:1 1978:1 1979:1 1980:1 1981:1  |EV| 
-0.74044064105868301339796744287014  |BT| (S (NP (DT (A))(NN (relationship))(JJ (renal))(NN (tumor))(NN (ASPS)))(ADVP (RB (initially)))(VP (VBD (suggested))(NP (JJ (cytogenetic))(NN (finding))(JJ (balanced))(-LRB- (-LRB-))(NN (X))(: (;))(CD (17))(-RRB- (-RRB-))(-LRB- (-LRB-))(NN (p11))(NN (.2))(: (;)))(NP (CD (q25)))(-RRB- (-RRB-))(SBAR (S (NP (NP (CD (two))(NN (case)))(, (,))(NP (NN (ASPL-TFE3))(NN (fusion))(NN (transcript))))(VP (VBD (confirmed))(NP (JJ (reverse))(NN (transcriptase-polymerase))(NN (chain))(NN (reaction)))))))) |ET|  |BS| 272:E05.393.620.500.725 273:H01.158.273.343.180 274:C04.588.945.947.535 275:C23.888  |ES| 2:1 7:1 10:1 14:1 19:1 69:1 217:1 223:1 768:1 922:1 923:1 924:1 925:1 926:1 927:1 928:1 929:1 930:1 931:1 932:1 933:1 934:1 935:1 936:1 937:1 938:1 939:1 940:1 941:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (MicroRNA-21))(JJ (potential))(NN (link))(JJ (non-alcoholic))(NN (fatty))(NN (liver))(NN (disease))(JJ (hepatocellular))(NN (carcinoma)))(PP (IN (via))(NP (NN (modulation))(NN (HBP1-p53-Srebp1c))(NN (pathway)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 104:C04.557.470.200.025.255 184:D13.150.650.319 576:D12.776.260.103.500.750.500 577:C06.552.241.519  |ES| 19:1 303:1 304:1 383:1 596:1 827:1 836:1 998:1 1608:1 1945:1 2068:1 2069:1 2070:1 2071:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NP (NN (Activation))(JJ (p53-dependent))(NN (apoptosis))(JJ (acute))(NN (ablation))(NN (glycogen))(NN (synthase))(NN (kinase-3beta)))(NP (JJ (colorectal))(NN (cancer))(NN (cell))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 38:Z01.058.290.120.180 39:G04.299.139.160 40:Z01.542.248.700 41:A11  |ES| 17:1 18:1 19:1 66:1 87:1 88:1 89:1 90:1 91:1 92:1 93:1 94:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NP (JJ (Differential))(NN (effect))(JJ (oncogenic))(NN (K-Ras))(NN (N-Ras))(NN (proliferation)))(, (,))(NP (NN (differentiation))(NN (tumor))(NN (progression))(NN (colon)))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 16:C23.550.291.656 51:C04.588.274.476.411.307.180 74:G04.299.151 279:D27.888.569.100  |ES| 2:1 7:1 13:1 19:1 48:1 75:1 113:1 215:1 299:1 953:1 1905:1 1906:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (DT (These)))(VP (VBP (result))(VP (VBP (suggest))(NP (S (NP (NN (K-sam))(NN (overexpression)))(VP (VBN (associated))(NP (JJ (malignant))(NN (phenotype))(JJ (undifferentiated))(NN (type))(NN (stomach))(NN (cancer)))))(, (,))(NP (JJ (infiltrative))(NN (growth))(NN (metastasis))))))) |ET|  |BS| 45:G07.700.320.249 80:G05.695 113:C04.697.650 231:C04.557.465.625.600.380.590 232:D02.886.030.676.180  |ES| 2:1 18:1 19:1 101:1 102:1 152:1 169:1 236:1 543:1 792:1 796:1 801:1 802:1 803:1 804:1 805:1 806:1  |EV| 
5.1698483124001830546490054985043  |BT| (NP (NNS (Alterations))(NP (NP (NN (hMSH2))(NN (gene)))(VP (VBN (linked))(NP (ADJP (QP (RB (approximately))(CD (60)))(NN (%)))(JJ (hereditary))(JJ (nonpolyposis))(NN (colon))(NN (cancer))(NN (case)))))) |ET|  |BS| 18:G05.365.590 30:Z01.058.290.190.800 31:D08.811.520.224.800 524:C04.588.274.476.411.307.190  |ES| 9:1 18:1 19:1 113:1 369:1 934:1 1363:1 1841:1 1842:1 1843:1 1844:1 1845:1 1846:1  |EV| 
-3.4623198085067201645870227366686  |BT| (NP (NP (NP (NN (Incubation))(NN (CRC))(NN (cell))(NN (miR-221))(NN (miR-222))(NN (inhibitor)))(SBAR (S (NP (VBD (reduced))(NN (proliferation))(NN (colony))(NN (formation)))(VP (VBN (compared))(NP (NN (control))(NN (cell)))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 20:G03.495 41:A11 109:I01.696.116  |ES| 19:1 43:1 50:1 94:1 140:1 141:1 245:1 289:1 299:1 314:1 380:1 452:1 517:1  |EV| 
-4.0414040084523890072887297719717  |BT| (FRAG (NP (ADVP (FW (In))(FW (vitro)))(PRN (, (,))(NP (NP (VBN (forced))(NN (expression))(NN (Cdx2))(JJ (human))(NN (colon))(NN (cancer))(NN (cell))(NN (line)))(SBAR (S (NP (VBN (retarded))(NN (wound))(NN (repair)))(VP (VBD (reduced))(NP (NN (migration)))))))(, (,))))(SBAR (IN (whereas))(S (NP (NN (inhibition))(NN (Cdx2))(NN (expression))(NN (RNA))(NN (interference)))(VP (VBD (enhanced))(NP (NN (migration))))))) |ET|  |BS| 43:F01.145.544 55:B01.050.150.900.649.801.400.112.400.400 89:G16.100.856.891 94:A11.251.210 122:C14.280.383 156:G05.355.315.203.374.790  |ES| 2:1 18:1 19:1 36:1 94:1 103:1 113:1 115:1 213:1 216:1 244:1 264:1 267:1 372:1 385:1 452:1 511:1 512:1 513:1 514:1 515:1 516:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (microRNA-146a)))(VP (VBZ (inhibits))(NP (NP (NN (cancer))(NN (metastasis)))(VP (VBG (downregulating))(NP (NN (VEGF))(JJ (dual))(NN (pathway))(JJ (hepatocellular))(NN (carcinoma))))))) |ET|  |BS| 104:C04.557.470.200.025.255 113:C04.697.650 122:C14.280.383 184:D13.150.650.319  |ES| 18:1 19:1 303:1 304:1 383:1 615:1 806:1 2064:1 2065:1 2066:1 2067:1  |EV| 
5.1698483124001830546490054985043  |BT| (S (NP (NN (miR-185)))(VP (VBZ (inhibits))(NP (NP (JJ (hepatocellular))(NN (carcinoma))(NN (growth)))(VP (VBG (targeting))(NP (NN (DNMT1/PTEN/Akt))(NN (pathway))))))) |ET|  |BS| 45:G07.700.320.249 104:C04.557.470.200.025.255 122:C14.280.383 378:D08.811.913.696.620.682.700.755  |ES| 19:1 102:1 303:1 304:1 383:1 615:1 616:1 2094:1 2095:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Expression))(NN (KLK13))(NN (KLK14))(NN (gene)))(VP (VBN (examined))(NP (NP (NN (mRNA))(NN (protein))(NN (level))(NN (cohort))(CD (57))(NN (patient)))(NP (NP (JJ (non-small-cell))(NN (lung))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (NSCLC)))(-RRB- (-RRB-))))))) |ET|  |BS| 6:G05.360.340.024.340 50:M01.643 110:C04.588.894.797.520.109.220.249 111:D13.444.735.544 112:D12.776.097.820  |ES| 4:1 9:1 10:1 14:1 18:1 19:1 120:1 121:1 249:1 316:1 322:1 323:1 324:1 325:1 326:1 327:1 328:1 329:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (DT (A))(NN (TRAMP/COX))(CD (-2))(JJ (knockout))(NN (mouse))(NN (model)))(ADVP (RB (also)))(VP (VBD (generated))(VP (VB (determine))(NP (NN (effect))(NN (loss))(NN (COX-2))(NN (gene))(NN (prostate))(NN (tumorigenesis))(NN (TRAMP))(NN (mouse)))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 29:B01.050.050.136.500.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 32:C04.697.098.500 33:C04.697.098 34:A05.360.444.575  |ES| 5:1 9:1 19:1 32:1 52:1 69:1 70:1 71:1 72:1 73:1 74:1 75:1 76:1 77:1 78:1 79:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NP (JJ (Basal))(NN (cell))(NN (carcinosarcoma))(NN (PTCH1))(NN (mutation)))(NP (JJ (epithelial))(JJ (sarcomatoid))(JJ (primary))(NN (tumor))(NN (component))(JJ (sarcomatoid))(NN (metastasis))))) |ET|  |BS| 8:C04 18:G05.365.590 41:A11 113:C04.697.650 303:C04.557.450.795 304:C04.557.435.290  |ES| 7:1 19:1 34:1 94:1 127:1 344:1 806:1 1021:1 1052:1 1053:1 1054:1 1055:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (DT (The))(CD (two))(NN (library)))(ADVP (RB (differentially)))(VP (VBD (expressed))(SBAR (S (NP (NN (gene)))(VP (MD (may))(VP (VB (provide))(NP (NN (basis))(JJ (new))(NN (insight))(NN (clue))(NN (finding))(JJ (novel))(NN (lung))(JJ (cancer-related))(NN (gene)))))))))(: (;))(S (NP (JJ (several))(NN (gene)))(ADVP (RB (newly)))(VP (VBD (found))(NP (NP (NN (lung))(NN (cancer))(NN (ERGIC3)))(VP (VBG (seeming))(NP (JJ (novel))(NN (lung))(JJ (cancer-related))(NN (gene)))))))) |ET|  |BS| 9:G05.360.340.024.340.375.500 182:A04.411 259:D12.776.395.240.150.500 275:C23.888 343:G05.360.325 344:M01.438  |ES| 6:1 9:1 18:1 19:1 37:1 104:1 217:1 239:1 262:1 328:1 491:1 691:1 711:1 712:1 891:1 927:1 933:1 1138:1 1139:1 1140:1 1141:1 1142:1 1143:1 1144:1 1145:1 1146:1  |EV| 
-5.1698483124001830546490054985043  |BT| (NP (NP (NP (JJ (Transient))(JJ (stable))(NN (overexpression))(NN (mir-660)))(S (VP (VBG (using))(S (NP (NN (miRNA)))(VP (VBP (mimic))(SBAR (S (NP (VBN (reduced))(NP (NN (migration)))(, (,))(NP (NN (invasion)))(, (,))(NP (NN (proliferation))(NN (property))))(VP (VBD (increased))(NP (NP (NN (apoptosis))(NN (p53))(JJ (wild-type))(NN (lung))(NN (cancer))(NN (cell)))(PRN (-LRB- (-LRB-))(NP (NP (NN (NCI-H460)))(, (,))(NP (NN (LT73)))(, (,))(NP (NN (A549))))(-RRB- (-RRB-))))))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 39:G04.299.139.160 41:A11 120:I01.409.418.750.600.480.150 184:D13.150.650.319  |ES| 2:1 8:1 10:1 12:1 14:1 18:1 19:1 47:1 89:1 94:1 152:1 299:1 328:1 350:1 360:1 363:1 364:1 373:1 452:1 514:1 567:1 620:1 839:1 840:1 841:1 842:1  |EV| 
-3.3181184040964808446005918085575  |BT| (S (NP (DT (This))(NN (study)))(VP (VBZ (provides))(SBAR (S (NP (NP (JJ (first))(JJ (quantitative))(NN (analysis))(JJ (discrete))(NN (CRKI))(NN (CRKII))(NN (protein))(NNS (isoforms)))(SBAR (S (NP (JJ (human))(NN (lung))(NN (tumor)))(VP (VBZ (provides))(NP (NN (evidence))(NN (C-CRK))(NN (proto-oncogene)))))))(VP (MD (may))(VP (VB (foment))(NP (JJ (aggressive))(NN (phenotype))(NN (lung))(NN (cancer))))))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 80:G05.695 162:F01.145.126.125 235:G05.360.340.024.340.375.500.791 236:D12.644.360.024.318 237:C04.588.894.797.520 238:D12.776.800  |ES| 4:1 7:1 18:1 19:1 36:1 38:1 131:1 236:1 328:1 491:1 538:1 563:1 661:1 807:1 815:1 816:1 817:1 818:1 819:1 820:1 821:1 822:1 823:1  |EV| 
-2.0350351752023527751589426770806  |BT| (S (SBAR (IN (Although))(S (NP (NP (NN (therapy)))(VP (VBG (targeting))(NP (JJ (high))(NN (EphA1))(NN (expression)))))(VP (VBP (seem))(NP (JJ (plausible))(NN (CRC))))))(, (,))(S (NP (NN (loss))(NN (expression)))(VP (VBD (advanced))(NP (NN (disease)))))(VP (VBZ (suggests))(SBAR (S (NP (NP (NP (JJ (potential))(NN (risk)))(VBN (targeted))(NN (therapy)))(, (,))(VP (VBG (selecting))(NP (NN (loss))(NN (expression))))(, (,)))(VP (MD (might))(VP (VB (contribute))(NP (NN (disease))(NN (progression))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 16:C23.550.291.656 38:Z01.058.290.120.180 40:Z01.542.248.700 52:E02 61:E05.318.740.600.800 288:C23.550.288  |ES| 2:1 16:1 19:1 32:1 48:1 107:1 115:1 130:1 171:1 178:1 245:1 331:1 450:1 616:1 798:1 827:1 994:1 995:1 996:1 997:1 998:1 999:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NN (Penta-1,2,3,4,6-O-galloyl-beta-D-glucose)))(VP (VP (VBZ (induces))(SBAR (S (NP (NN (p53)))(VP (VBZ (inhibits))(NP (NN (STAT3))(NN (prostate))(NN (cancer))(NN (cell))(NN (vitro)))))))(VP (VBZ (suppresses))(NP (NN (prostate))(NN (xenograft))(NN (tumor))(NN (growth)))(FW (vivo))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 41:A11 45:G07.700.320.249 82:D12.644.360.024.342.300 91:D09.546.359.448 92:E04.936.764 93:A01.941.875 122:C14.280.383 202:C04.588.945.440.770  |ES| 7:1 12:1 18:1 19:1 77:1 94:1 102:1 214:1 216:1 251:1 265:1 378:1 615:1 685:1 686:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (PP (IN (Among))(NP (ADJP (RB (frequently))(VBN (deleted)))(JJ (chromosomal))(NN (site))))(, (,))(NP (NN (LOH))(NN (chromosome))(NN (3p)))(VP (VBD (detected))(NP (NN (MM)))(, (,))(S (VP (VBG (suggesting))(S (NP (NN (presence)))(NP (CD (one))(NP (JJ (several))(NN (tumour))(NN (suppressor))(NN (gene))(JJ (important))(NN (role)))(NN (development))(NN (disease)))))))) |ET|  |BS| 12:Z01.542.049 15:F01.829.316.616 206:G05.360.340.024.340.375.249 289:A11.284.187 290:G05.365.590.029.530 291:F03.625.421  |ES| 2:1 9:1 19:1 31:1 35:1 262:1 346:1 698:1 700:1 902:1 998:1 1000:1 1001:1 1002:1 1003:1 1004:1 1005:1 1006:1 1007:1 1008:1 1009:1 1010:1 1011:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (NP (NN (CDX2)))(, (,))(NP (NN (master))(NN (regulator))(JJ (intestinal))(NN (phenotype)))(, (,)))(VP (VBN (shown))(NP (NN (play))(JJ (tumor-suppressive))(NN (role))(NN (colon))(NN (cancer))))) |ET|  |BS| 15:F01.829.316.616 30:Z01.058.290.190.800 31:D08.811.520.224.800 47:A03.556.124 51:C04.588.274.476.411.307.180 79:I03.450.642.693 80:G05.695  |ES| 2:1 18:1 19:1 31:1 109:1 113:1 114:1 177:1 234:1 235:1 236:1 237:1 238:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (VP (VBG (Combining))(NP (NN (kallistatin))(NN (gene))(NN (therapy))(NN (meloxicam))(NN (treat))(JJ (hepatocellular))(NN (carcinoma))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 52:E02 104:C04.557.470.200.025.255  |ES| 9:1 19:1 52:1 130:1 303:1 304:1 1087:1 1088:1 1089:1 1090:1  |EV| 
-5.1698483124001830546490054985043  |BT| (S (NP (PRP (We)))(VP (VBD (investigated))(SBAR (IN (whether))(S (NP (NN (microRNA))(NN (miR-221))(NN (miR-222)))(VP (VBP (regulate))(NP (NP (NP (NN (NF-kappaB))(NN (signal))(NN (transducer))(NN (activator))(NN (transcription))(CD (3)))(PRN (-LRB- (-LRB-))(NP (NN (STAT3)))(-RRB- (-RRB-))))(NP (NN (activation))(JJ (human))(NN (CRC))(NN (cell))(NN (line))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 55:B01.050.150.900.649.801.400.112.400.400 94:A11.251.210 184:D13.150.650.319 210:D12.776.260.600 249:G05.355.315.800 250:E07.305.812  |ES| 10:1 14:1 19:1 36:1 94:1 140:1 141:1 221:1 225:1 245:1 251:1 264:1 403:1 487:1 714:1 843:1 857:1 858:1 859:1 860:1 861:1 862:1  |EV| 
